[go: up one dir, main page]

WO2010092924A1 - Pentose-assimilating recombinant escherichia coli that produce ethanol and method for manufacturing ethanol using same - Google Patents

Pentose-assimilating recombinant escherichia coli that produce ethanol and method for manufacturing ethanol using same Download PDF

Info

Publication number
WO2010092924A1
WO2010092924A1 PCT/JP2010/051779 JP2010051779W WO2010092924A1 WO 2010092924 A1 WO2010092924 A1 WO 2010092924A1 JP 2010051779 W JP2010051779 W JP 2010051779W WO 2010092924 A1 WO2010092924 A1 WO 2010092924A1
Authority
WO
WIPO (PCT)
Prior art keywords
strain
ethanol
escherichia coli
glucose
pentose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2010/051779
Other languages
French (fr)
Japanese (ja)
Inventor
一良 太田
裕則 浜砂
可也 泉
佳子 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miyazaki NUC
Original Assignee
University of Miyazaki NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miyazaki NUC filed Critical University of Miyazaki NUC
Publication of WO2010092924A1 publication Critical patent/WO2010092924A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • C12P7/08Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
    • C12P7/10Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P25/00Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • C12P7/065Ethanol, i.e. non-beverage with microorganisms other than yeasts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • the present invention relates to an ethanol-producing recombinant Escherichia coli, more specifically, a recombinant Escherichia coli capable of efficiently producing ethanol etc. from a saccharified liquid of biomass such as lignocellulose containing a polysaccharide that generates pentose by hydrolysis, and It relates to a method for producing ethanol and the like.
  • bioethanol As a renewable energy, particularly bioethanol made from lignocellulose-derived saccharide, which is a so-called “carbon neutral” feedstock.
  • lignocellulose-derived carbohydrates are carbohydrates that “do not compete with food”, unlike food-derived carbohydrates such as sucrose and starch. Effective utilization of lignocellulose-derived carbohydrates is important for the future development of civilization.
  • the lignocellulose-derived sugar solution contains sugars derived from cellulose and hemicellulose which constitute the cell wall of plants, and unlike sugar solutions derived from sugarcane juice or starch, C5 sugars such as xylose and arabinose produced from hemicellulose. That is, it contains pentose.
  • the conventional general ethanol production method is S.H. Utilizes ethanol fermentation using cerevisiae .
  • S. Although cerevisiae has high fermentative ability of C6 sugars such as glucose and fructose, that is, hexose, it hardly lacks fermentative ability of pentose. Therefore, the conventional S.I.
  • lignocellulose sugar solution was used in the ethanol production method using cerevisiae , hexose was converted to ethanol, but pentose such as xylose coexisting in the solution was not converted to ethanol.
  • the KO11 strain included several problems.
  • One of them is the problem of diauxie. That is, microorganisms such as Escherichia coli have the property that when hexose and pentose coexist, hexose is used first and then pentose is used from the advantage of energy production. Due to dioxy, the use of pentose is delayed from the beginning of fermentation. Therefore, ethanol production in a mixed system of hexose and pentose has a long total fermentation time, and a big problem remains in economic efficiency.
  • PTS phosphoenolpyruvate-dependent phosphotransferase system
  • PtsG Glucose phosphotransferase
  • E. coli of Eiteman et al. Is lactic acid, not ethanol.
  • E. coli used here by Eiteman et al. Is completely phenotypically different from the KO11 strain, which disrupts genes that produce organic acids such as lactic acid and acetic acid and distributes most of the ability to produce organic acids to ethanol production. Is different.
  • anaerobic fermentation is performed from the middle.
  • Nichols et al. Show that Escherichia coli having the disrupted ptsG gene has the ability to ferment glucose, arabinose, and xylose alone or in a mixture to produce ethanol, and that glucose and pentose are simultaneously used by this Escherichia coli. (Non-Patent Document 4).
  • mutant strain used here is one in which the gene of Zymomonas mobilis involved in ethanol production has been introduced by transformation with a plasmid. Is essential.
  • This strain is cultured under absolute anaerobic conditions in which the gas phase is replaced with CO 2 and nitrogen. These culture conditions are not suitable for mass culture on an industrial scale in terms of cost and equipment.
  • the present invention provides Escherichia coli in which the problem of dioxy, which is a drawback of the KO11 strain which is an ethanol-producing genetically modified Escherichia coli, is improved or solved, an ethanol production method using the same, and an ethanol-containing solution produced thereby. With the goal.
  • the present inventors produced ethanol-producing genetically modified Escherichia coli with suppressed glucose uptake and relatively enhanced xylose utilization, and by making a difference in carbohydrate utilization in E. coli, I thought it would be possible to release it.
  • a novel recombinant Escherichia coli (KO11 ⁇ P strain; KO11 delta (KO11 delta)) that efficiently utilizes xylose, which is pentose in the presence of glucose, by suppressing the uptake of glucose, which is a typical hexose, in a mixed solution of hexose and pentose. delta) P strain).
  • the inventors of the present invention have modified the KO11 strain (KO11 ⁇ P strain) that has been modified so that glucose is not taken up by PtsG by destroying a gene ( ptsG ) encoding PtsG, which is a membrane protein that takes in glucose. And the utilization of carbohydrates was compared with the original strain KO11. As a result, it was found that the utilization rate of xylose in a mixed solution of hexose and pentose was increased, and the present invention was completed.
  • the Escherichia coli of the present invention is a genetically modified Escherichia coli in which pentose utilization is relatively enhanced by suppressing glucose uptake, and the pentose is used for ethanol production.
  • the Escherichia coli of the present invention retains the advantages of the KO11 strain in addition to the pentose availability.
  • the Escherichia coli of the present invention has a gene related to alcohol production in the chromosome rather than in the plasmid, so that it is not necessary to use antibiotics for maintaining the trait and stable ethanol production is possible. For this reason, there are advantages such as cost advantage during mass production.
  • the strain of the present invention produces ethanol well under aerobic conditions and does not require anaerobic conditions, so it should be cultured under normal conditions with a general fermenter. Can do. Therefore, the Escherichia coli of the present invention has very high industrial production suitability.
  • ethanol since the utilization of pentose in a mixed solution of hexose and pentose is improved by modifying the ptsG gene, ethanol can be produced in a shorter time than before. Therefore, it has a higher ethanol production capacity than the KO11 strain.
  • the Escherichia coli of the present invention has all the advantages of the KO11 strain, but unexpectedly has additional advantages that the KO11 strain did not originally have.
  • the Escherichia coli of the present invention is excellent in reusability because the cells are robust and strong compared to other Escherichia coli such as the KO11 strain which is the original strain. That is, the number of times the cells used in the fermentation process are collected and used in the fermentation process of a new sugar solution can be increased.
  • the Escherichia coli of the present invention produces a large amount of vitamin B2 in parallel with ethanol production and releases it into the culture medium. Therefore, it is also possible to collect and use vitamin B2 from the culture solution.
  • FIG. 1 is a diagram showing xylose consumption in an M9 sugar mixed medium of KO11 strain (white circle; ⁇ ) and KO11 ⁇ P strain (black square; ⁇ ).
  • FIG. 2 is a diagram showing glucose consumption in the M9 sugar mixed medium of the KO11 strain (white circle; ⁇ ) and the KO11 ⁇ P strain (black square; ⁇ ).
  • FIG. 3 is a diagram showing ethanol production in the M9 sugar mixed medium of the KO11 strain (white circle; ⁇ ) and the KO11 ⁇ P strain (black square; ⁇ ).
  • FIG. 1 is a diagram showing xylose consumption in an M9 sugar mixed medium of KO11 strain (white circle; ⁇ ) and KO11 ⁇ P strain (black square; ⁇ ).
  • FIG. 2 is a diagram showing glucose consumption in the M9 sugar mixed medium of the KO11 strain (white circle; ⁇ ) and the KO11 ⁇ P strain (black square; ⁇ ).
  • FIG. 3 is a diagram showing ethanol production in the M9 sugar
  • KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain, and ⁇ P-1 and ⁇ P-2 for the KO11 ⁇ P strain, respectively.
  • FIG. 5 Panels (C) and (D) are diagrams showing the remaining amounts of glucose (panel (C)) and xylose (panel (D)) of the KO11 strain and the KO11 ⁇ P strain when repeatedly fermented, respectively.
  • KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain, and ⁇ P-1 and ⁇ P-2 for the KO11 ⁇ P strain, respectively.
  • FIG. 6 is a graph showing vitamin B2 (riboflavin) production of the KO11 strain (black bar) and the KO11 ⁇ P strain (shaded bar).
  • FIG. 7 is a diagram for explaining the ptsG gene that is disrupted by homologous recombination shown in the Examples.
  • the recombinant Escherichia coli of the present invention is characterized in that a gene ( ptsG ) encoding PtsG that is a glucose uptake membrane protein is disrupted or deleted, is pentose- assimilating , and has ethanol-producing ability. To do.
  • disruption of a gene means that the gene itself is present but that the protein encoded by the gene is not expressed and that the protein encoded by the gene does not function normally. Means that a functional expression product of the gene is not produced in a cell having the gene.
  • the disruption of the gene may be an amino acid modification of the coding region, may interfere with the movement of the gene product to the membrane, or may be inactivation of the promoter region.
  • a “deficiency” of a gene refers to a state in which the gene itself does not exist.
  • the recombinant Escherichia coli of the present invention is transformed into, for example, a commonly available Escherichia coli so as to have a genotype similar to that of the KO11 strain at least with respect to sugar metabolism and organic acid metabolism. It can be obtained by destroying or deleting a gene ( ptsG ) encoding a PtsG protein.
  • the KO11 strain is already commercially available as the standard strain ATCC 55124 strain and can be easily obtained. Use of this strain as the original strain is advantageous because the Escherichia coli of the present invention can be easily produced by disrupting or deleting the ptsG gene.
  • the amino acid and base sequence of the ptsG gene of Escherichia coli is known, and examples thereof include base numbers 1159446 to 1160879 (SEQ ID NO: 1 in the sequence listing) of GenBank AC — 000091 (Escherichia coli K-12 strain substr. W3110).
  • the ptsG gene is disrupted or deleted by methods such as homologous recombination and the transposon method (see, for example, Kimata et al., Proc. Natl. Acad. Sci. USA, vol. 94, pp. 12914-12919, Nov. 1997). It can be carried out.
  • a method for confirming whether the ptsG gene is disrupted or deleted in a recombinant is known and can be arbitrarily selected by those skilled in the art.
  • the genomic DNA of the recombinant as a template PCR was performed using primers specific for the ptsG gene, genomic PCR method to confirm that no product is amplified product of ptsG gene, DIG (Digoxigenin-deoxyuridine monophosphate)
  • DIG Digoxigenin-deoxyuridine monophosphate
  • the recombinant E. coli of the present invention can be cultured well under the same conditions as general E. coli.
  • Specific examples of the culture conditions include the same conditions as in the fermentation step in ethanol production described below.
  • the ethanol production method of the present invention is characterized by using the above-described recombinant Escherichia coli of the present invention as a fermentation microorganism in the fermentation step.
  • the fermentation process may be any of a batch system, a continuous system, or a modified system thereof. Therefore, in the framework of a conventionally known ethanol production process, the method using the recombinant E. coli of the present invention in the fermentation step is the method of the present invention.
  • the raw material for producing ethanol using the recombinant Escherichia coli of the present invention may be a biological raw material (biomass), and may be plant or animal. These biomass contain carbohydrates. Carbohydrates are generally classified into monosaccharides, oligosaccharides and polysaccharides, but the raw materials used are pentose or hexose and biomass containing monosaccharides including pentose, or pentose or hexose by hydrolysis and Any of the oligosaccharide which produces
  • the method of the present invention is characterized in that pentose can be efficiently converted to ethanol even in the presence of hexose.
  • a raw material such as a saccharified liquid of lignocellulose containing pentose
  • the method of the present invention is used. The advantage is particularly noticeable.
  • Terrestrial plant biomass includes, for example, woody lignocelluloses such as hardwoods and conifers; herbaceous lignocelluloses (including palms and bamboos) such as switchgrass and cedar; cereals such as corn and rice, cassava, potatoes, etc. Examples include starch raw materials containing potatoes, and sugar raw materials containing sugarcane, sugar beet, molasses, etc., and biomass residues such as rice straw and bagasse after the production of these starches and sugars are also included. Also included are wood pulp, waste paper, building waste, municipal waste, pruning material, food waste and the like. Aquatic plant biomass includes aquatic plants such as water hyacinth; seaweeds such as kombu and seaweed. Also included are chlorella and phytoplankton, which are plant microorganisms. Animal biomass includes shrimp and crab shells and whey.
  • the method for producing ethanol from biomass varies slightly depending on the characteristics of the raw materials used, but it can basically be composed of a pretreatment process, a saccharification process, and a fermentation process, and in general, a concentration (distillation) process and a dehydration process. Etc. Steps other than the fermentation step can be omitted in some cases.
  • the method of the present invention requires a fermentation process, but other processes may or may not be present as necessary.
  • the method of the present invention can include a pretreatment step suitable for each raw material as required.
  • biomass is stored after being collected from the production area and subjected to a treatment such as drying in order to prevent alteration and decomposition until it is used.
  • a biomass pulverization step is performed after collection or just before ethanol production.
  • a dry grinding method or a wet grinding method is adopted as necessary.
  • the saccharification step is carried out by acid treatment, alkali treatment, neutral salt treatment, hydrothermal treatment, enzyme treatment or the like alone or in combination.
  • starch when starchy raw materials are used, starch can be liquefied and saccharified using amylase and pullulanase.
  • lignocellulosic biomass As pretreatment of lignocellulosic biomass, concentrated sulfuric acid treatment (Peoria method, Scholtani-Leone method, Hokkaido method, etc.), dilute sulfuric acid treatment (Scholer method, Madison method, improved Madison method, Soviet method, two-stage decomposition method, etc.) , Acid decomposition such as sulfurous acid treatment, concentrated hydrochloric acid treatment (Pergius-Ryinau method, new Reinau method, etc.), hydrochloric acid gas treatment (Brodle method, Dalbuofen method, Elan method, Noguchi Laboratory method, etc.), and hydrolysis by enzymes Etc. Cellulases, hemicellulases, and the like are used as enzymes for pretreatment of lignocellulosic biomass. After completion of saccharification, the used chemicals and insoluble biomass components are separated as necessary. By these treatments, a saccharified solution containing monosaccharide, oligosaccharide, solubilized lign
  • the method of the present invention requires a fermentation process.
  • 100 g of saccharide becomes about 50 g of ethanol and about 50 g of CO 2 (in this case, the fermentation rate is 100%.
  • the saccharide refers to pentose and hexose).
  • the material used for the fermentation process is the above-described biomass itself (a saccharide raw material, a monosaccharide raw material, etc.) or a saccharified liquid obtained through a pretreatment step and / or a saccharification step as necessary.
  • the content of pentose and / or hexose in these materials reaches several percent (W / V) to 80% (W / V) or more, but the material used in the present invention is pentose and / or hexose content.
  • a relatively high value is desirable. More preferably, the content of pentose and / or hexose is 10% (W / V) or more, and most preferably 30% (W / V) or more. If the initial content is less than 10% (W / V), it can be concentrated and used as 10% (W / V) or more.
  • the fermentation process can be suitably performed at pH 4 or higher, particularly at pH 5.5 or higher, and fermentation proceeds well at least up to pH 8. Considering contamination prevention, fermentation rate, and a small change in conditions with other processes, it is advantageous to carry out at pH 5-7, especially at pH 5.5-6.5.
  • temperature conditions should just be 20 degreeC or more, and a fermentation process can be performed suitably to 40 degreeC. Considering the fermentation rate and the small change in conditions with other processes, it is advantageous to carry out the reaction at 30 ° C. to 40 ° C., particularly 35 ° C. to 40 ° C.
  • the optimum pH and temperature conditions for the fermentation process are pH 5.5 to 6.5 and 35 to 40 ° C.
  • the reaction time is generally 6 to 72 hours, but can be appropriately selected according to the characteristics of the biomass or saccharified solution used. According to the method of the present invention, a high fermentation rate of generally 85 to 98% can be realized.
  • the fermented liquor contains the produced ethanol.
  • Ethanol produced in the fermentation process is generally recovered and purified from the fermentation broth through a distillation process and a dehydration process.
  • the implementation conditions of these steps are well known. From the fermentation liquid containing ethanol to the ethanol purified to high purity obtained through the subsequent additional steps, such as a distillation step and a dehydration step, are collectively referred to as an ethanol-containing solution for convenience.
  • a mash solid-liquid separation step after the fermentation step.
  • Moromi's solid-liquid separation step is known, and examples of the method include filtration (filter cloth, screen, membrane, etc.), centrifugation, decantation and the like.
  • filtration filter cloth, screen, membrane, etc.
  • centrifugation decantation
  • decantation decantation
  • purified ethanol refers to “ethanol” by the Japanese Pharmacopoeia, that is, an aqueous solution containing 95.1 to 95.6% (V / V) ethanol at 15 ° C. This is industrially useful as a raw material for the production of ethyl acetate and the like.
  • Anhydrous ethanol according to the Japanese Pharmacopoeia is an aqueous solution containing 99.5% (V / V) or more of ethanol at 15 ° C., and is industrially used as a fuel.
  • Ethanol obtained by the method of the present invention can be used as fuel (petroleum alternative energy, gasoline additive, etc.), industrial raw material (chemical raw material), food additive, etc. Can also be used in the manufacture of pharmaceuticals and hygiene products.
  • Vitamin B2 riboflavin
  • Vitamin B2 produced from the KO11 ⁇ P strain accumulates even when dissolved in the culture solution, but accumulates as crystals in the culture solution when the production amount increases.
  • the culture solution containing vitamin B2 derived from the KO11 ⁇ P strain may be used as a pharmaceutical raw material, a food additive, or a feed additive as vitamin B2 crystals, or can be used as it is for a feed or the like after the cells are completely sterilized.
  • Vitamin B2 accumulated as crystals in the culture solution can be recovered and purified by a general purification method.
  • the culture solution is heat-treated (60 ° C., 30 minutes) to sterilize the KO11 ⁇ P strain, and then the crystal fraction is centrifuged to collect the precipitate.
  • This precipitate is further acid-treated (hydrochloric acid or sulfuric acid about 2%) for DNA degradation (depurination) to obtain about 96% vitamin B2. It can be further crystallized with an acid solvent to obtain a product with a content of about 98%.
  • KO11 ⁇ P strain by disruption of ptsG on the chromosome of KO11 strain (1) Preparation of homologous recombination fragment
  • the homologous recombination fragment is FRT of “Quick & Easy E. coli Gene Deletion kit” (trade name, Gene Bridges GmbH).
  • a PGK-gb2-neo-FRT cassette was used as a template, and a homologous sequence (50base) of the target gene ptsG gene (SEQ ID NO: 1) was added to both ends of this cassette by PCR.
  • the homologous sequence (50base) was added by the three-step PCR method shown in (a) to (c). Table 1 lists the primer sequences used.
  • This reaction solution was set on a thermal cycler. After warming at 94 ° C. for 2 minutes to activate KOD-plus-DNA polymerase, 30 cycles of 94 ° C. for 15 seconds, 55 ° C. for 30 seconds, and 68 ° C. for 2 minutes were performed.
  • the gel was immersed in a cyber-safe staining solution (trade name “Cyber-safe DNA gel staining reagent (1 ⁇ TAE)”, Invitrogen), and stained for 20 minutes while gently stirring. Ultraviolet light was irradiated, and the band of the amplified fragment was confirmed at a position near 1662 bp. The remaining 45 ⁇ L of the PCR reaction solution was subjected to CIA treatment, ethanol precipitation, and rinsing. Thereafter, the pellets dried under reduced pressure were dissolved in 20 ⁇ L of Milli Q water.
  • a cyber-safe staining solution trade name “Cyber-safe DNA gel staining reagent (1 ⁇ TAE)”, Invitrogen
  • the PCR-amplified fragment (50 ⁇ L) obtained in (1)-(iii) above was mixed with 10 ⁇ L of 6 ⁇ Loading Dye, and this solution (60 ⁇ L) was mixed on a 1% TAE agarose gel at 60 V for 60 minutes. Electrophoresis was performed. At this time, a 1 kbp marker was simultaneously run in another lane as an index for confirming the position of the amplified fragment to be extracted. After the electrophoresis, the gel was immersed in a cyber-safe staining solution and stained for 20 minutes with gentle stirring. The band of the amplified fragment was confirmed at a position near 1747 bp by irradiating with ultraviolet rays, and the gel containing the band was recovered. The gel containing the recovered amplified fragment was extracted from the gel using “QIAquick Gel Extraction Kit”. Hereinafter, the extracted fragment is referred to as “ptsG homologous recombination fragment”.
  • the KO11 strain was inoculated into an LB / Cm liquid medium, and cultured with shaking at 37 ° C. and 60 rpm until the turbidity reached OD 660 ⁇ 0.6. After transferring 1.4 mL of this culture solution to a tube and centrifuging at 6,000 rpm for 5 minutes, the supernatant was discarded, and the remaining pellet was resuspended in 1 mL of sterile water.
  • the centrifugation and resuspension operations were performed a total of three times to wash the cells, and finally resuspended in 40 ⁇ L of sterilized water.
  • 1 ⁇ L of pRed / ET (amp) was added and mixed, and transferred to an electroporation cuvette.
  • electroporation with Gene Pulser II and Pulse Controller PLUS at a voltage of 2.5 kV, a resistance of 200 ⁇ , and a capacitance of 25 ⁇ F immediately add 400 ⁇ L of LB liquid medium and transfer to a 1.5 mL tube.
  • the culture was shaken at 150 ° C. for 1 hour (150 rpm).
  • kanamycin sulfate (Wako Pure Chemical Industries) was added to a final concentration of 30 ⁇ g / mL and chloramphenicol to a final concentration of 600 ⁇ g / mL, and dispensed into a petri dish.
  • KO11 (Red / ET) was inoculated into an LB / Cm liquid medium, and cultured under shaking at 30 ° C. and 150 rpm until the turbidity reached OD660 ⁇ 0.3.
  • the fragment (1068 bp) shown in lowercase letters with an underline in FIG. 7 is destroyed in the ptsG gene.
  • the uppercase letters indicate the portions corresponding to the sequences of the primers P1, P3, and P5
  • the underlined uppercase letters indicate the portions that correspond to the sequences of the primers P2, P4, and P6.
  • a white colony of the transformant obtained in the above (3)-(ii) was picked with a sterilized toothpick and added as a template to the reaction solution to prepare a PCR reaction solution. After setting in a thermal cycler and heating at 94 ° C. for 5 minutes to activate the HibriPol TM DNA polymerase, denaturation at 94 ° C. for 30 seconds, annealing at 55 ° C. for 30 seconds, extension reaction at 72 ° C. for 30 seconds, These three stages were repeated 32 cycles. After completion of PCR, electrophoresis was carried out on a 1.0% (W / V) agarose gel at 100 V for 30 minutes. A clone that was confirmed to be amplified in the vicinity of 1970 bp in the ptsG- disrupted strain was designated as “KO11 ⁇ P” strain, which was glycerol stock ( ⁇ 84 ° C.).
  • the KO11 ⁇ P strain was deposited on January 26, 2009 at the National Institute of Advanced Industrial Science and Technology, Patent Biological Depositary Center (1st, 1st East, Tsukuba City, Ibaraki Prefecture, Central 6th), with accession number FERM P-21758 was given. In addition, on January 4, 2010, it was transferred to FERM BP-11221 and transferred to an international deposit under the “Budapest Convention on the International Approval of Deposits of Microorganisms in Patent Procedures”.
  • the M9 mixed sugar medium was prepared as follows. A 100 mL Erlenmeyer flask to which 58.2 mL of an aqueous solution containing 4.8 g of glucose and 3.2 g of xylose was added was autoclaved. To this 100 mL Erlenmeyer flask, add 4 mL of 20 ⁇ M9 salts, 0.8 mL of 100 mM MgSO 4 , 16 mL of 1M phosphate buffer, and 1 mL of 20% (W / V) casamino acid to make a total volume of 80 mL. Medium with concentrations of 6% (W / V) and 4% (W / V), respectively, was designated as M9 mixed sugar medium.
  • KO11 strain, KO11 ⁇ P strain Glycerol stock (30% (W / V)) was used.
  • LB liquid medium 1% (W / V) NaCl, 1% (W / V) Bacto TM Peptone (Nippon Becton Dickinson), 0.5% (W / V) East Extract (Nippon Pharmaceutical), It was dissolved in distilled water so as to be 5% agar (Wako Pure Chemical Industries), and sterilized by autoclave.
  • LB / Cm plate 1.5% (W / V) agar was added to the LB liquid medium, and autoclaved.
  • chloramphenicol (Wako Pure Chemical Industries) was added to a final concentration of 600 ⁇ M and dispensed into a petri dish.
  • LB / Cm liquid medium After autoclaving 5 mL of LB liquid medium, chloramphenicol was added to a final concentration of 600 ⁇ g / mL.
  • M9 mixed sugar medium Concentrated sulfuric acid (Wako Pure Chemical Industries)
  • Incubator (Tokyo Rika Kikai Co., Ltd.) -Toothpick: Placed in a 100 mL beaker and sterilized by autoclave.
  • the KO11 strain and the KO11 ⁇ P strain were streaked using a toothpick on an LB / Cm plate (LB / Cm and Km plates were used in the case of the KO11 ⁇ P strain), and then statically cultured at 37 ° C. for 16 hours. Thereafter, a single colony was inoculated into 5 mL of LB / Cm liquid medium in a clean bench, and cultured with shaking at 37 ° C. and 60 rpm for 16 hours. Furthermore, 100 ⁇ L of the culture solution was inoculated into 100 mL of LB liquid medium in a clean bench, and cultured with shaking at 30 ° C. and 150 rpm for 16 hours. This culture solution was used as a preculture solution.
  • a sample for liquid chromatography was prepared by sterilizing 600 ⁇ L of the culture supernatant collected by sampling with a microsyringe.
  • glucose solutions and xylose solutions having concentrations of 0, 2, 4, 6, 8, and 10% (W / V) were used as standards.
  • FIG. 1 shows the change in xylose concentration in the culture of the KO11 strain and the KO11 ⁇ P strain in an M9 sugar mixed medium.
  • the KO11 strain (white circle; ⁇ ) hardly used xylose, whereas the KO11 ⁇ P strain (black square; ⁇ ) was able to use xylose.
  • KO11 strain consumed 16% of the initial xylose concentration, whereas KO11 ⁇ P strain consumed 55%. That is, it was found that the xylose consumption of the KO11 ⁇ P strain is three times or more that of the KO11 strain, and the KO11 ⁇ P strain suppresses glucose consumption and efficiently consumes xylose in the presence of glucose.
  • FIG. 2 shows the change in glucose concentration in the culture of the KO11 strain and the KO11 ⁇ P strain in an M9 sugar mixed medium.
  • FIG. 3 shows the change in ethanol concentration in the culture of the KO11 strain and KO11 ⁇ P strain in the M9 sugar mixed medium. It was found that the KO11 ⁇ P strain (black square; ⁇ ) produced ethanol with a production rate of 0.8%, although the ethanol production rate was slightly inferior to that of the KO11 strain (white circle; ⁇ ).
  • Ethanol fermentation test with jar fermenter Fermentation test with jar fermenter was performed using Escherichia coli KO11 strain and KO11 ⁇ P strain.
  • YPD medium (Difco, Lot No. 7242780) ⁇ Glucose (Wako Pure Chemical Industries, special grade, Lot No. ALP4694) ⁇ Xylose (Wako Pure Chemical Industries, special grade, Lot No. PEH5709) ⁇ 99.5% ethanol (Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222) ⁇ Rotary shake incubator (Takasugi Mfg.
  • YPD medium manufactured by Difco, Lot No. 7242780; containing 3% (W / V) glucose
  • xylose manufactured by Wako Pure Chemical Industries, Ltd., special grade, Lot No. YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding PEH5709) to 3% (W / V) was used.
  • the culture solution was centrifuged at 5,000 rpm for 5 minutes in a high-speed cooling centrifuge (model 6500, manufactured by Kubota Corporation) to separate the cells and the medium.
  • the obtained cell pellet was washed with physiological saline and used for a fermentation test.
  • the 850 mg of the bacterial cell pellet obtained in the pre-culture was collected by wet weight, and the whole amount was inoculated into the medium in the jar fermenter. Thereafter, the cells were cultured in an aerobic state at 37 ° C. and 180 rpm, and the pH was automatically controlled in the pH range of 5.5 to 6.0 with NaOH. The cells were continuously cultured for 134 hours from the start of the culture. Sampling was performed at an appropriate time. The sampled culture solution was centrifuged at 8,000 rpm for 5 minutes, and the ethanol concentration and the residual sugar (glucose and xylose) concentrations that were not used were measured by the following method.
  • the sample is diluted 1 to 20 times so that the ethanol concentration in the sample is within the range of 0.2 to 1.0% (V / V), and the gas chromatograph for ethanol analysis (GL Sciences) (The column is “Porapak Type R” (trade name; manufactured by Waters) column, the carrier gas is nitrogen, and the flow rate is 60 mL / min).
  • ethanol manufactured by Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222
  • Isopropanol was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of ethanol with respect to the internal standard.
  • the sample was diluted 10 to 100 times so that the sugar concentration of the sample was in the range of 10 to 300 ppm, and subjected to separation and quantification using an ion column chromatograph for sugar analysis (DIONEX).
  • the column used was PA-1 (trade name; manufactured by DIONEX), and elution was performed with water alone at a rate of 1 mL / min.
  • 5 types of monosaccharides (glucose, mannose, galactose, xylose, arabinose) are separated under the same conditions for quantification of eluted sugars, and a standard curve with excellent linearity in the measurement area and the weight of each sugar is obtained.
  • a condition was set.
  • Deoxyglucose was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of each sugar relative to the internal standard.
  • the content of monosaccharide contained in the sample was calculated from the conversion factor of each obtained sugar and the measured area.
  • the KO11 ⁇ P strain (labeled “ ⁇ P”; black square; ⁇ ) has a final ethanol concentration (panel (A)) of 4.59% even under aerobic conditions.
  • Residual sugar at the time (panel (B)) is 1.02% for glucose (displayed as “glucose ⁇ P”; white triangle; ⁇ ), and 0.59% for xylose (displayed as “xylose ⁇ P”; white circle; ⁇ ) there were.
  • KO11 strain (white circle; ⁇ ) has a final ethanol concentration (panel (A)) of 3.77%, and residual sugar (panel (B)) at this time is indicated by glucose (“glucose KO11”; black)
  • glucose glucose
  • xylose labeleled “xylose KO11”; black square; ⁇
  • YPD medium manufactured by Difco, Lot No. 7242780; containing 3% (W / V) glucose
  • xylose manufactured by Wako Pure Chemical Industries, Ltd., special grade, Lot No. PEH5709
  • YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding 3% (W / V) was used.
  • the culture solution was centrifuged at 5,000 rpm for 5 minutes in a high-speed cooling centrifuge (model 6500, manufactured by Kubota Corporation) to separate the cells and the medium.
  • the obtained cell pellet was washed with physiological saline and used for a fermentation test.
  • the supernatant and the cells were separated by centrifugation at 5,000 rpm for 5 minutes using a centrifuge (Model MX-305, manufactured by TOMY).
  • the cells were centrifuged again at 5,000 rpm for 1 minute to completely remove the liquid, and then the wet cell weight was measured.
  • the cells were again dispersed in 20 mL of a new mixed sugar solution, and the next cycle of fermentation was performed. This was repeated a total of 4 times.
  • the supernatant collected after each cycle was further centrifuged at 8,000 rpm for 5 minutes, and the concentrations of ethanol, glucose and xylose were measured.
  • the sample is diluted 1 to 20 times so that the ethanol concentration in the sample is within the range of 0.2 to 1.0% (V / V), and the gas chromatograph for ethanol analysis (GL Sciences) (“Porapak® Type®” (trade name; manufactured by Waters) column was used, the carrier gas was nitrogen, and the flow rate was 60 mL / min).
  • GL Sciences gas chromatograph for ethanol analysis
  • ethanol manufactured by Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222
  • Isopropanol was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of ethanol with respect to the internal standard.
  • the sample was diluted 10 to 100 times so that the sugar concentration of the sample was in the range of 10 to 300 ppm, and subjected to separation and quantification using an ion column chromatograph for sugar analysis (manufactured by DIONEX Corporation).
  • the column used was PA-1, and elution was performed with water alone at a rate of 1 mL / min.
  • 5 types of monosaccharides (glucose, mannose, galactose, xylose, arabinose) are separated under the same conditions for quantification of eluted sugars, and a standard curve with excellent linearity in the measurement area and the weight of each sugar is obtained.
  • a condition was set.
  • Deoxyglucose was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of each sugar relative to the internal standard.
  • the content of monosaccharide contained in the sample was calculated from the conversion factor of each obtained sugar and the measured area.
  • KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain and ⁇ P-1 and ⁇ P-2 for the KO11 ⁇ P strain, respectively.
  • the KO11 strain and the KO11 ⁇ P strain were subjected to a fermentation test under the same conditions, the KO11 strain could not be repeatedly fermented, but the KO11 ⁇ P strain could be repeatedly fermented three times (panel (A): ethanol production). Amount; Panel (B): Cell weight). Since PtsG that is deficient in the KO11 ⁇ P strain is a membrane protein, it is considered that in the KO11 ⁇ P strain, the properties of the cell membrane changed and the robustness of the cells increased.
  • YPD medium (Difco, Lot No. 7724780; containing 3% (W / V) glucose) and xylose (Wako Pure Chemical Industries, special grade, Lot No. PEH5709) 3% (W / A YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding V) was used.
  • a 500 mL Erlenmeyer flask was dispensed with 100 mL of the aforementioned YPD medium containing 3% glucose (W / V) and 3% xylose (W / V), and aseptically inoculated with 30 mg wet cell weight.
  • An aluminum cap was used for the lid of the Erlenmeyer flask.
  • the culture was carried out using a rotary shake incubator (model TS-RS12L (24), manufactured by Takasugi Seisakusho Co., Ltd.) at 37 ° C. and 120 rpm for 15 hours and 24 hours.
  • the results are shown in FIG.
  • the vertical axis represents the amount of vitamin B2 (mg) in 100 g of the culture solution.
  • the KO11 ⁇ P strain (“ ⁇ P”) produced vitamin B2 in a larger amount than the KO11 strain by culturing in the YPD medium.
  • Coniferous wood chips and hardwood wood chips were used as biomass.
  • the black liquor produced when these biomasses were pulped by sulfite treatment was used as biomass sugar liquid (saccharified liquid).
  • Calcium hydroxide was appropriately added to the biomass sugar solution to adjust to pH 6.0, and then heated at 80 ° C. for 3 hours to decompose furfural in the sugar solution.
  • the biomass sugar solution was produced three times each on different days.
  • the sugar in the biomass sugar solution thus obtained was quantified according to the sugar analysis method described above, and the sugar composition was evaluated.
  • Table 2 shows the concentration in each sugar solution.
  • the sugar solution derived from hardwood is a sugar solution rich in xylose due to the decomposition of xylan, which is hemicellulose in wood.
  • the sugar solution derived from conifers is a sugar solution rich in mannose because hemicellulose is mannan.
  • the ethanol concentration produced by the use of biomass sugar solution was 1.00% for conifers and 0.03% for hardwoods for the KO11 strain, while 0.99% for conifers for the KO11 ⁇ P strain. %, Broad-leaved tree was 0.26%. Therefore, compared to the original KO11 strain, the KO11 ⁇ P strain had the same ethanol productivity using the coniferous-derived biomass sugar solution, and when the hardwood-derived biomass sugar solution was used, It was found that ethanol productivity was higher than that of a certain KO11 strain.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Disclosed are Escherichia coli that improve or resolve the diauxy problems that were a flaw in the KO11 strain of recombinant ethanol-producing Escherichia coli, a method for manufacturing ethanol using the same, and an ethanol-containing solution produced thereby. Disclosed are recombinant Escherichia coli obtained by destroying or eliminating the ptsG gene of the KO11 strain of Escherichia coli.

Description

ペントース資化性エタノール生産組換え大腸菌及びこれを用いるエタノールの製造方法Pentose assimilating ethanol-producing recombinant Escherichia coli and method for producing ethanol using the same

 本発明は、エタノール生産組換え大腸菌、より詳しくは加水分解によりペントースを生成する多糖類を含むリグノセルロース等のバイオマスの糖化液からの効率的なエタノール等の生産が可能な組換え大腸菌、及びこれを用いるエタノール等の製造方法に関する。 The present invention relates to an ethanol-producing recombinant Escherichia coli, more specifically, a recombinant Escherichia coli capable of efficiently producing ethanol etc. from a saccharified liquid of biomass such as lignocellulose containing a polysaccharide that generates pentose by hydrolysis, and It relates to a method for producing ethanol and the like.

 大気中のCOの濃度の上昇による地球温暖化の防止のためには、化石燃料によらない新エネルギーの開発が急務である。このような新エネルギーの中で、再生可能なエネルギーとして、バイオエタノール、特にいわゆる「カーボンニュートラル」な原料であるリグノセルロース由来の糖質を原料としたバイオエタノールに注目が集まっている。 In order to prevent global warming due to an increase in the concentration of CO 2 in the atmosphere, there is an urgent need to develop new energy that does not rely on fossil fuels. Among such new energies, attention has been focused on bioethanol as a renewable energy, particularly bioethanol made from lignocellulose-derived saccharide, which is a so-called “carbon neutral” feedstock.

 リグノセルロース自体を人類は直接的に食糧として利用できない。そのため、リグノセルロース由来の糖質は、ショ糖や澱粉といった食糧由来の糖質と違って、「食糧と競合しない」糖質である。このリグノセルロース由来の糖質の有効活用は、人類の今後の発展のためには重要である。 リ Lignocellulose itself cannot be used directly as food. Therefore, lignocellulose-derived carbohydrates are carbohydrates that “do not compete with food”, unlike food-derived carbohydrates such as sucrose and starch. Effective utilization of lignocellulose-derived carbohydrates is important for the future development of mankind.

 しかし、カーボンニュートラルであり食糧と競合しないリグノセルロース由来の糖質にも、問題点が存在する。たとえば、「ペントース発酵」の問題である。リグノセルロース由来の糖液は、植物の細胞壁を構成するセルロースとヘミセルロースとに由来する糖を含み、サトウキビの絞り液や澱粉に由来する糖液と違って、ヘミセルロースから生成するキシロースやアラビノースといったC5糖、すなわちペントースを含有する。 However, there are also problems with carbohydrates derived from lignocellulose that are carbon neutral and do not compete with food. For example, the problem of “pentose fermentation”. The lignocellulose-derived sugar solution contains sugars derived from cellulose and hemicellulose which constitute the cell wall of plants, and unlike sugar solutions derived from sugarcane juice or starch, C5 sugars such as xylose and arabinose produced from hemicellulose. That is, it contains pentose.

 従来の一般的なエタノール製造法はS. cerevisiaeを使ったエタノール発酵を利用する。S. cerevisiaeは、グルコースやフルクトースといったC6糖、すなわちヘキソースの発酵能は高いものの、ペントースの発酵能がほとんど欠落している。そのため、従来のS.cerevisiaeを使ったエタノール製造方法でリグノセルロース糖液を用いると、ヘキソースはエタノールに変換されるが、液中に共存するキシロース等のペントースはエタノールに変換されない、という大きな問題点があった。 The conventional general ethanol production method is S.H. Utilizes ethanol fermentation using cerevisiae . S. Although cerevisiae has high fermentative ability of C6 sugars such as glucose and fructose, that is, hexose, it hardly lacks fermentative ability of pentose. Therefore, the conventional S.I. When lignocellulose sugar solution was used in the ethanol production method using cerevisiae , hexose was converted to ethanol, but pentose such as xylose coexisting in the solution was not converted to ethanol.

 この問題を解決するために、フロリダ大学のIngramと太田らは、ヘキソースかペントースかを問わず利用することができる大腸菌に、アルコール生産の能力を付与することにより、エタノール発酵を大腸菌で行えば、リグノセルロース由来の糖液中のヘキソース及びペントースをエタノールに変換できると考えた。そして、エタノール生産に関与するZymomonas mobilisの遺伝子を大腸菌B株に導入することにより、アルコール生産性組換え大腸菌の作出に成功した(特許文献1、2、及び非特許文献1)。 In order to solve this problem, Ingram and Ota et al. At the University of Florida are able to use ethanol fermentation in Escherichia coli by giving the ability of alcohol production to E. coli that can be used regardless of whether it is hexose or pentose. We thought that hexose and pentose in lignocellulose-derived sugar solution could be converted to ethanol. Then, by introducing the Zymomonas mobilis gene involved in ethanol production into Escherichia coli B strain, an alcohol-producing recombinant Escherichia coli was successfully produced (Patent Documents 1 and 2 and Non-Patent Document 1).

 Ingramと太田らの発案で作出されたアルコール生産能を有するこの組換え大腸菌は、KO11株と呼ばれ、ヘキソース及びペントースを含むリグノセルロース糖液からエタノールを生産できる有用な微生物として、世界的に利用されている。 This recombinant Escherichia coli with the ability to produce alcohol created by the idea of Ingram and Ota et al. Is called KO11 strain and is used worldwide as a useful microorganism capable of producing ethanol from lignocellulose sugar solution containing hexose and pentose. Has been.

 しかし、KO11株は、いくつかの問題点も包含していた。そのひとつがダイオキシー(Diauxie)の問題である。すなわち、大腸菌をはじめとして、微生物には、ヘキソースとペントースとが共存した場合、エネルギー生産の優位性から、先にヘキソースを利用してその後でペントースを利用するという性質がある。ダイオキシーのためにペントースの利用は発酵の初期から遅れる。そのため、ヘキソース及びペントース混合系でのエタノール生産は、トータルの発酵時間が長くなり、経済性に大きな問題が残されていた。 However, the KO11 strain included several problems. One of them is the problem of diauxie. That is, microorganisms such as Escherichia coli have the property that when hexose and pentose coexist, hexose is used first and then pentose is used from the advantage of energy production. Due to dioxy, the use of pentose is delayed from the beginning of fermentation. Therefore, ethanol production in a mixed system of hexose and pentose has a long total fermentation time, and a big problem remains in economic efficiency.

 大腸菌においては、ホスホエノールピルビン酸依存性リン酸転移システム(PTS;Phosphoenolpyruvate-dependent carbohydrate phosphotransferase system)がグルコースを輸送する。この系に関与する膜タンパク質として、グルコースホスホトランスフェラーゼ(PtsG)が知られている(非特許文献2)。 In Escherichia coli, a phosphoenolpyruvate-dependent phosphotransferase system (PTS) transports glucose. Glucose phosphotransferase (PtsG) is known as a membrane protein involved in this system (Non-patent Document 2).

 Eitemanらは、エタノール非生産性の通常の大腸菌を使ってptsG遺伝子を破壊する操作を行い、グルコース共存下でキシロースを効率よく利用することのできる組換え大腸菌を得た(非特許文献3)。 Eiteman et al. Performed an operation to destroy the ptsG gene using normal E. coli that does not produce ethanol, and obtained recombinant E. coli that can efficiently use xylose in the presence of glucose (Non-patent Document 3).

 しかし、Eitemanらの組換え大腸菌が生産する物質は乳酸であり、エタノールではない。また、Eitemanらによりここで使用された大腸菌は、乳酸や酢酸といった有機酸を生産する遺伝子を破壊し有機酸を生産する能力の大部分をエタノール生産に振り分けているKO11株とは表現型が全く異なっている。さらに、この培養では途中から嫌気発酵が行われている。 However, the substance produced by recombinant E. coli of Eiteman et al. Is lactic acid, not ethanol. In addition, E. coli used here by Eiteman et al. Is completely phenotypically different from the KO11 strain, which disrupts genes that produce organic acids such as lactic acid and acetic acid and distributes most of the ability to produce organic acids to ethanol production. Is different. Furthermore, in this culture, anaerobic fermentation is performed from the middle.

 Nicholsらは、ptsG遺伝子を破壊した大腸菌が、グルコース、アラビノース、キシロースをそれぞれ単独で又は混合物で発酵してエタノールを生産する能力を有すること、及びこの大腸菌によってグルコースとペントースとが同時に利用されることを見出した(非特許文献4)。 Nichols et al. Show that Escherichia coli having the disrupted ptsG gene has the ability to ferment glucose, arabinose, and xylose alone or in a mixture to produce ethanol, and that glucose and pentose are simultaneously used by this Escherichia coli. (Non-Patent Document 4).

 しかし、ここで使用された変異株は、プラスミドを用いた形質転換によってエタノール生産に関与するZymomonas mobilisの遺伝子を導入したものであり、培養液への数種の抗生物質の添加が形質維持のために不可欠である。また、この株は気相をCOと窒素とに置換した絶対嫌気条件で培養されている。これらの培養条件は、コストや設備等の点で、工業的規模での大量培養には適さない。 However, the mutant strain used here is one in which the gene of Zymomonas mobilis involved in ethanol production has been introduced by transformation with a plasmid. Is essential. This strain is cultured under absolute anaerobic conditions in which the gas phase is replaced with CO 2 and nitrogen. These culture conditions are not suitable for mass culture on an industrial scale in terms of cost and equipment.

米国特許第5000000号US Patent No. 5000000 米国特許第5424202号US Pat. No. 5,424,202

Ohta et al. (1991) Appl. Environ. Microbiol. 57:893-900Ohta et al. (1991) Appl. Environ. Microbiol. 57: 893-900 Gosset, Microbial Cell Factories 2005, 4:14Gosset, Microbial Cell Factories 2005, 4:14 Eiteman, MA et al., “A Substrate-Selective Co-Fermentation Strategy with Escherichia coli Produces Lactate by Simultaneously Consuming Xylose and Glucose,” Biotechnology and Bioengineering, published online 29 August 2008 in Wiley InterScienceEiteman, MA et al., “A Substrate-Selective Co-Fermentation Strategy with Escherichia coli Produces Lactate by Simultaneously Consuming Xylose and Glucose,” Biotechnology and Bioengineering, published online 29 August 29 Nichols, NN, et al., Appl. Microbiol. Biotechnol. (2001) 56:120-125Nichols, NN, et al., Appl. Microbiol. Biotechnol. (2001) 56: 120-125

 本発明は、エタノール生産性遺伝子組換え大腸菌であるKO11株の欠点であるダイオキシーの問題が改善又は解決された大腸菌、及びそれを用いるエタノール製造方法及びそれによって製造されるエタノール含有溶液を提供することを目的とする。 The present invention provides Escherichia coli in which the problem of dioxy, which is a drawback of the KO11 strain which is an ethanol-producing genetically modified Escherichia coli, is improved or solved, an ethanol production method using the same, and an ethanol-containing solution produced thereby. With the goal.

 本発明者らは、グルコースの取り込みを抑制し、相対的にキシロースの利用能を高めたエタノール生産性遺伝子組換え大腸菌を作製し、大腸菌において糖質の利用性に差をつけることにより、ダイオキシーの解除が可能になると考えた。そして、ヘキソースとペントースとの混合溶液においてヘキソースの代表格であるグルコースの取り込みを抑制することで、グルコース共存下においてペントースであるキシロースを効率よく利用する、新規組換え大腸菌(KO11ΔP株;KO11デルタ(delta)P株)を作出した。 The present inventors produced ethanol-producing genetically modified Escherichia coli with suppressed glucose uptake and relatively enhanced xylose utilization, and by making a difference in carbohydrate utilization in E. coli, I thought it would be possible to release it. A novel recombinant Escherichia coli (KO11ΔP strain; KO11 delta (KO11 delta)) that efficiently utilizes xylose, which is pentose in the presence of glucose, by suppressing the uptake of glucose, which is a typical hexose, in a mixed solution of hexose and pentose. delta) P strain).

 具体的には、本発明者らは、グルコースを取り込む膜タンパク質であるPtsGをコードする遺伝子(ptsG)を破壊して、PtsGによるグルコースの取込みを行わないように改変されたKO11株(KO11ΔP株)を作出し、糖質の利用性を元株のKO11株と比較したところ、ヘキソースとペントースとの混合溶液でのキシロースの利用速度が上がっていることを見出し、本発明を完成した。 Specifically, the inventors of the present invention have modified the KO11 strain (KO11ΔP strain) that has been modified so that glucose is not taken up by PtsG by destroying a gene ( ptsG ) encoding PtsG, which is a membrane protein that takes in glucose. And the utilization of carbohydrates was compared with the original strain KO11. As a result, it was found that the utilization rate of xylose in a mixed solution of hexose and pentose was increased, and the present invention was completed.

 すなわち、本発明によれば
 〔1〕 ptsG遺伝子が破壊され又は欠損した、大腸菌KO11株の改変体である組換え大腸菌;
 〔2〕 好気的条件下でペントース資化性である、前記〔1〕記載の組換え大腸菌;
 〔3〕 大腸菌KO11株と比較してエタノール生産性及びビタミンB2生産性が高い、前記〔1〕又は〔2〕記載の組換え大腸菌;
 〔4〕 受託番号FERM P-21758(FERM BP-11221)を有する、組換え大腸菌;
 〔5〕 前記〔1〕~〔4〕のいずれか1項記載の組換え大腸菌を使用してバイオマス糖化液を発酵させる工程を含む、エタノール及び/又はビタミンB2製造方法;
 〔6〕 発酵工程が、好気的条件下で行われる、前記〔5〕記載の方法;
 〔7〕 バイオマス糖化液が、ヘキソースとペントースとが共存する糖化液である、前記〔5〕又は〔6〕記載の方法;
 〔8〕 発酵工程の前にバイオマスを糖化する工程を含む、前記〔5〕~〔7〕のいずれか1項記載の方法;
 〔9〕 発酵工程の後にもろみの固液分離工程、及びエタノールの蒸留工程及び/又は脱水工程を含む、前記〔5〕~〔8〕のいずれか1項記載の方法;
 〔10〕 前記〔5〕~〔9〕のいずれか1項記載の方法を用いて製造されたエタノール含有溶液、
が提供される。
That is, according to the present invention, [1] a recombinant Escherichia coli that is a variant of Escherichia coli KO11 strain in which the ptsG gene is disrupted or deleted;
[2] The recombinant Escherichia coli according to the above [1], which is pentose assimilating under aerobic conditions;
[3] The recombinant Escherichia coli according to [1] or [2], wherein ethanol productivity and vitamin B2 productivity are high as compared to Escherichia coli KO11 strain;
[4] Recombinant Escherichia coli having accession number FERM P-21758 (FERM BP-11221);
[5] A method for producing ethanol and / or vitamin B2, comprising a step of fermenting a biomass saccharified solution using the recombinant Escherichia coli according to any one of [1] to [4];
[6] The method according to [5] above, wherein the fermentation step is performed under aerobic conditions;
[7] The method according to [5] or [6] above, wherein the biomass saccharified solution is a saccharified solution in which hexose and pentose coexist.
[8] The method according to any one of [5] to [7] above, comprising a step of saccharifying biomass before the fermentation step;
[9] The method according to any one of [5] to [8] above, comprising a solid-liquid separation step of the mash after the fermentation step, and a distillation step and / or a dehydration step of ethanol;
[10] An ethanol-containing solution produced using the method according to any one of [5] to [9],
Is provided.

 本発明の大腸菌は、グルコースの取込みを抑制することによって、相対的にペントース利用能を高め、そのペントースをエタノール生産に利用させた遺伝子組換え大腸菌である。 The Escherichia coli of the present invention is a genetically modified Escherichia coli in which pentose utilization is relatively enhanced by suppressing glucose uptake, and the pentose is used for ethanol production.

 本発明の大腸菌は、ペントース利用能に加えて、KO11株の利点を保持している。たとえば、KO11株と同様、本発明の大腸菌はアルコール生産に関する遺伝子をプラスミドではなく染色体に有しているので、形質維持のための抗生物質の使用が不要で、安定したエタノール生産が可能である。このため、大量生産時にコスト的に有利であること等の利点がある。さらに、KO11株と同様、本発明の株は好気的条件下での培養で良好にエタノールを生産し、嫌気的条件を必要としないため、一般的なファーメンターで通常の条件で培養することができる。したがって、本発明の大腸菌は非常に高い工業生産適性を有する。 The Escherichia coli of the present invention retains the advantages of the KO11 strain in addition to the pentose availability. For example, like the KO11 strain, the Escherichia coli of the present invention has a gene related to alcohol production in the chromosome rather than in the plasmid, so that it is not necessary to use antibiotics for maintaining the trait and stable ethanol production is possible. For this reason, there are advantages such as cost advantage during mass production. Furthermore, as with the KO11 strain, the strain of the present invention produces ethanol well under aerobic conditions and does not require anaerobic conditions, so it should be cultured under normal conditions with a general fermenter. Can do. Therefore, the Escherichia coli of the present invention has very high industrial production suitability.

 本発明によれば、ptsG遺伝子の改変によりヘキソース及びペントースの混合溶液中でのペントースの利用性が上がっているため、従来よりも短時間でのエタノール生産が可能となる。したがって、KO11株よりも高いエタノール生産能力を有している。 According to the present invention, since the utilization of pentose in a mixed solution of hexose and pentose is improved by modifying the ptsG gene, ethanol can be produced in a shorter time than before. Therefore, it has a higher ethanol production capacity than the KO11 strain.

 さらに、本発明の大腸菌は、KO11株の利点をすべて保持している一方、予期せぬことに、KO11株がもともと有していなかった、さらなる利点を有することも判明した。たとえば、本発明の大腸菌は、元株であるKO11株等の他の大腸菌と比較して細胞が堅牢であり、強固であるため、再利用性に優れている。すなわち、発酵工程に使用した菌体を回収して、新たな糖液の発酵工程に使用する回数を、増加することができる。また、驚くべきことに本発明の大腸菌は、エタノールの生産と並行してビタミンB2を大量に生産し培養液中に放出することも判明した。したがって、培養液からビタミンB2を回収し利用することも可能である。 Furthermore, it was also found that the Escherichia coli of the present invention has all the advantages of the KO11 strain, but unexpectedly has additional advantages that the KO11 strain did not originally have. For example, the Escherichia coli of the present invention is excellent in reusability because the cells are robust and strong compared to other Escherichia coli such as the KO11 strain which is the original strain. That is, the number of times the cells used in the fermentation process are collected and used in the fermentation process of a new sugar solution can be increased. Surprisingly, it was also found that the Escherichia coli of the present invention produces a large amount of vitamin B2 in parallel with ethanol production and releases it into the culture medium. Therefore, it is also possible to collect and use vitamin B2 from the culture solution.

 上記の種々の利点により、本発明の大腸菌を用いることによって、非常に効率的なエタノール生産、特にリグノセルロース由来糖液を使っての従来よりも効率的なエタノール生産が可能となる。したがって、リグノセルロース由来原料を用いるエタノール製造工場の大きさを従来のものより小さくすることができ、設備投資を少なくし、尚且つ、発酵時間の短縮により時間当たりの生産効率を大きく上昇させ、経済性を向上させることができる。さらに、KO11株よりも多くのビタミンB2を生産するので、エタノール及びビタミンB2の同時生産も可能である。 Due to the above-mentioned various advantages, by using the Escherichia coli of the present invention, very efficient ethanol production, in particular, more efficient ethanol production than conventional using lignocellulose-derived sugar solution becomes possible. Therefore, the size of the ethanol production plant using the lignocellulose-derived raw material can be made smaller than the conventional one, the capital investment is reduced, and the production efficiency per hour is greatly increased by shortening the fermentation time. Can be improved. Furthermore, since more vitamin B2 is produced than KO11 strain, ethanol and vitamin B2 can be produced simultaneously.

図1は、KO11株(白丸;○)及びKO11ΔP株(黒正方形;■)のM9糖混合培地におけるキシロース消費を示す図である。FIG. 1 is a diagram showing xylose consumption in an M9 sugar mixed medium of KO11 strain (white circle; ◯) and KO11ΔP strain (black square; ■). 図2は、KO11株(白丸;○)及びKO11ΔP株(黒正方形;■)のM9糖混合培地におけるグルコース消費を示す図である。FIG. 2 is a diagram showing glucose consumption in the M9 sugar mixed medium of the KO11 strain (white circle; ◯) and the KO11ΔP strain (black square; ■). 図3は、KO11株(白丸;○)及びKO11ΔP株(黒正方形;■)のM9糖混合培地におけるエタノール産生を示す図である。FIG. 3 is a diagram showing ethanol production in the M9 sugar mixed medium of the KO11 strain (white circle; ◯) and the KO11ΔP strain (black square; ■). 図4は、KO11株及びKO11ΔP株のグルコース7%(W/V)・キシロース3%(W/V)含有培地におけるジャーファーメンターでのエタノール産生(パネル(A))及び培地中の残糖量(パネル(B))を示す図である。パネル(A)において、KO11=白丸;○、KO11ΔP(「ΔP」(delta P))=黒正方形;■;パネル(B)において、グルコース KO11=黒菱形;◆、キシロース KO11=黒正方形;■、グルコース KO11ΔP(「グルコース ΔP」)=白三角;△、キシロース KO11ΔP(「キシロース ΔP」)=白丸;○である。FIG. 4 shows ethanol production in a jar fermenter (Panel (A)) in a medium containing 7% (W / V) glucose and 3% (W / V) glucose of KO11 strain and KO11ΔP strain, and the amount of residual sugar in the medium. It is a figure which shows (panel (B)). In panel (A), KO11 = white circle; ○, KO11ΔP (“ΔP” (delta P)) = black square; ■; in panel (B), glucose KO11 = black rhombus; ◆, xylose KO11 = black square; Glucose KO11ΔP (“glucose ΔP”) = white triangle; Δ, xylose KO11ΔP (“xylose ΔP”) = white circle; 図5、パネル(A)及び(B)は、繰り返し発酵させた場合のKO11株(白丸;○、黒丸;●)及びKO11ΔP株(白三角;△、黒三角;▲)のエタノール生産量(パネル(A))及び菌体重量(パネル(B))をそれぞれ示す図である。KO11-1、KO11-2はKO11株、ΔP-1、ΔP-2はKO11ΔP株の、それぞれ独立して行った2回の実験の結果を表す。FIG. 5, Panels (A) and (B) show the ethanol production (panels) of the KO11 strain (white circle; ○, black circle; ●) and KO11ΔP strain (white triangle; Δ, black triangle; ▲) after repeated fermentation. It is a figure which respectively shows (A)) and a microbial cell weight (panel (B)). KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain, and ΔP-1 and ΔP-2 for the KO11ΔP strain, respectively. 図5、パネル(C)及び(D)は、繰り返し発酵させた場合のKO11株及びKO11ΔP株のグルコース残量(パネル(C))及びキシロース残量(パネル(D))をそれぞれ示す図である。KO11-1、KO11-2はKO11株、ΔP-1、ΔP-2はKO11ΔP株の、それぞれ独立して行った2回の実験の結果を表す。黒いバーは1日目(1回目)、斜線のバーは2日目(2回目)の結果である。FIG. 5, Panels (C) and (D) are diagrams showing the remaining amounts of glucose (panel (C)) and xylose (panel (D)) of the KO11 strain and the KO11ΔP strain when repeatedly fermented, respectively. . KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain, and ΔP-1 and ΔP-2 for the KO11ΔP strain, respectively. The black bar is the result of the first day (first time), and the shaded bar is the result of the second day (second time). 図6は、KO11株(黒いバー)及びKO11ΔP株(斜線のバー)のビタミンB2(リボフラビン)生産量を示す図である。FIG. 6 is a graph showing vitamin B2 (riboflavin) production of the KO11 strain (black bar) and the KO11ΔP strain (shaded bar). 図7は、実施例において示した相同組換えによって破壊されるptsG遺伝子を説明する図である。FIG. 7 is a diagram for explaining the ptsG gene that is disrupted by homologous recombination shown in the Examples.

 組換え大腸菌
 本発明の組換え大腸菌は、グルコース取込み膜タンパク質であるPtsGをコードする遺伝子(ptsG)が破壊され又は欠損しており、ペントース資化性であり、エタノール生産能を有することを特徴とする。
Recombinant Escherichia coli The recombinant Escherichia coli of the present invention is characterized in that a gene ( ptsG ) encoding PtsG that is a glucose uptake membrane protein is disrupted or deleted, is pentose- assimilating , and has ethanol-producing ability. To do.

 本発明に関して、遺伝子の「破壊」は、その遺伝子自体は存在するが、その遺伝子がコードするタンパク質が発現されないようにすること、及びその遺伝子がコードするタンパクが正常に機能しないようにすること、の両方を含み、その遺伝子を有する細胞においてその遺伝子の機能的な発現産物が産生されないようにすることを意味する。たとえば、遺伝子の破壊は、コード領域のアミノ酸の改変であってもよく、遺伝子産物の膜への移動を妨害するようなものであってもよく、プロモーター領域の不活性化であってもよい。
 また、本発明において遺伝子の「欠損」は、その遺伝子自体が存在しない状態にすることを指す。
In the context of the present invention, “disruption” of a gene means that the gene itself is present but that the protein encoded by the gene is not expressed and that the protein encoded by the gene does not function normally. Means that a functional expression product of the gene is not produced in a cell having the gene. For example, the disruption of the gene may be an amino acid modification of the coding region, may interfere with the movement of the gene product to the membrane, or may be inactivation of the promoter region.
In the present invention, a “deficiency” of a gene refers to a state in which the gene itself does not exist.

 本発明の組換え大腸菌は、たとえば、一般的に入手できる大腸菌を、少なくとも糖代謝及び有機酸代謝に関してKO11株と同様の遺伝子型となるように、形質転換し、それと同時又はその前もしくは後に、PtsGタンパク質をコードする遺伝子(ptsG)を破壊又は欠損させることによって得ることができる。 The recombinant Escherichia coli of the present invention is transformed into, for example, a commonly available Escherichia coli so as to have a genotype similar to that of the KO11 strain at least with respect to sugar metabolism and organic acid metabolism. It can be obtained by destroying or deleting a gene ( ptsG ) encoding a PtsG protein.

 また、KO11株は、標準株ATCC 55124株として既に市販されており、容易に入手可能である。この株を元株として使用すれば、ptsG遺伝子を破壊又は欠損させることにより簡便に本発明の大腸菌を作製することができるので、有利である。 The KO11 strain is already commercially available as the standard strain ATCC 55124 strain and can be easily obtained. Use of this strain as the original strain is advantageous because the Escherichia coli of the present invention can be easily produced by disrupting or deleting the ptsG gene.

 大腸菌のptsG遺伝子のアミノ酸及び塩基配列は公知であり、たとえばGenBank AC_000091(大腸菌K-12株substr. W3110)の、塩基番号1159446~1160879(配列表の配列番号1)が挙げられる。 The amino acid and base sequence of the ptsG gene of Escherichia coli is known, and examples thereof include base numbers 1159446 to 1160879 (SEQ ID NO: 1 in the sequence listing) of GenBank AC — 000091 (Escherichia coli K-12 strain substr. W3110).

 ptsG遺伝子の破壊又は欠損は、相同組換え、トランスポゾン法(たとえばKimata et al., Proc. Natl. Acad. Sci. USA, vol.94, pp.12914-12919, Nov. 1997参照)等の方法により行うことができる。 The ptsG gene is disrupted or deleted by methods such as homologous recombination and the transposon method (see, for example, Kimata et al., Proc. Natl. Acad. Sci. USA, vol. 94, pp. 12914-12919, Nov. 1997). It can be carried out.

 組換え体においてptsG遺伝子が破壊され又は欠損しているかどうかを確認する方法は、公知であり、当業者は任意に選択することができる。たとえば、組換え体のゲノムDNAを鋳型として、ptsG遺伝子に特異的なプライマーを用いてPCR反応を行い、ptsG遺伝子の増幅産物が生成しないことを確認するゲノムPCR法、DIG(Digoxigenin-deoxyuridine monophosphate)等でラベルしたptsG遺伝子に特異的なプローブを用いてサザン・ブロッティングを行う方法等が挙げられる。また、組換え体においてPtsGタンパクが検出されないことを確認することもできる。 A method for confirming whether the ptsG gene is disrupted or deleted in a recombinant is known and can be arbitrarily selected by those skilled in the art. For example, the genomic DNA of the recombinant as a template, PCR was performed using primers specific for the ptsG gene, genomic PCR method to confirm that no product is amplified product of ptsG gene, DIG (Digoxigenin-deoxyuridine monophosphate) For example, a method of performing Southern blotting using a probe specific to the ptsG gene labeled with, for example. It can also be confirmed that no PtsG protein is detected in the recombinant.

 本発明の組換え大腸菌は、一般的な大腸菌と同様の条件下で良好に培養することができる。培養条件の具体例としては、後述するエタノール製造における発酵工程と同様の条件が挙げられる。 The recombinant E. coli of the present invention can be cultured well under the same conditions as general E. coli. Specific examples of the culture conditions include the same conditions as in the fermentation step in ethanol production described below.

 エタノールの製造方法
 本発明のエタノール製造方法は、発酵工程において発酵微生物として上述の本発明の組換え大腸菌を用いることを最大の特徴とする。発酵工程は、回分方式、連続方式又はそれらの変形の方式のいずれの方式であってもよい。したがって、従来公知のエタノール製造プロセスの枠組みにおいて、発酵工程に本発明の組換え大腸菌を用いるものは、本発明の方法である。
Ethanol production method The ethanol production method of the present invention is characterized by using the above-described recombinant Escherichia coli of the present invention as a fermentation microorganism in the fermentation step. The fermentation process may be any of a batch system, a continuous system, or a modified system thereof. Therefore, in the framework of a conventionally known ethanol production process, the method using the recombinant E. coli of the present invention in the fermentation step is the method of the present invention.

 本発明の組換え大腸菌を用いてエタノールの製造を行う際の原料は、生物由来原料(バイオマス)であればよく、植物性でも動物性でもよい。これらのバイオマスには糖質が含まれている。糖質は、一般に単糖類、オリゴ糖類及び多糖類に分類されるが、使用する原料は、ペントース又はヘキソース及びペントースを含む単糖類が含まれているバイオマス、又は加水分解することによりペントース又はヘキソース及びペントースを含む単糖類を生成するオリゴ糖類又は多糖類を含むバイオマスのいずれであってもよい。さらに、これらのバイオマスからの抽出物及び/又は分解物、及び抽出及び/又は分解残渣を原料として用いることもできる。 The raw material for producing ethanol using the recombinant Escherichia coli of the present invention may be a biological raw material (biomass), and may be plant or animal. These biomass contain carbohydrates. Carbohydrates are generally classified into monosaccharides, oligosaccharides and polysaccharides, but the raw materials used are pentose or hexose and biomass containing monosaccharides including pentose, or pentose or hexose by hydrolysis and Any of the oligosaccharide which produces | generates the monosaccharide containing a pentose, or the biomass containing a polysaccharide may be sufficient. Furthermore, the extract and / or decomposition product from these biomass, and an extraction and / or decomposition residue can also be used as a raw material.

 本発明の方法は、ヘキソース存在下でもペントースを効率よくエタノールに変換することができることを特徴とするものであり、ペントースを含有するリグノセルロースの糖化液等の原料を用いた場合に、本発明の利点が特に顕著である。 The method of the present invention is characterized in that pentose can be efficiently converted to ethanol even in the presence of hexose. When a raw material such as a saccharified liquid of lignocellulose containing pentose is used, the method of the present invention is used. The advantage is particularly noticeable.

 原料として使用可能なバイオマスの具体的な例としては、陸生植物バイオマス、水性植物バイオマス、動物性バイオマスが挙げられる。陸生植物バイオマスとしては、たとえば、広葉樹、針葉樹等の木本系リグノセルロース;スイッチグラス、ススキ等の草本系リグノセルロース(ヤシ類及び竹類を含む);コーン、イネ等の穀類、キャッサバ、馬鈴薯等のイモ類を含むデンプン原料;及びサトウキビ、テンサイ、糖蜜等を含む糖質原料が挙げられ、これらのデンプン質や糖質を製造した後の稲ワラ、バガス等のバイオマス残渣も含まれる。また、木材パルプ、古紙、建築廃材、都市ごみ、剪定材、食品廃棄物等も含まれる。
 水生植物バイオマスとしては、ホテイアオイ等の水草;コンブ、ワカメ等の海藻類が挙げられる。また、植物性微生物であるクロレラ、植物性プランクトン類も含まれる。
 動物性バイオマスとしてはエビ・カニ等の殻、乳清等が含まれる。
Specific examples of biomass that can be used as a raw material include terrestrial plant biomass, aqueous plant biomass, and animal biomass. Terrestrial plant biomass includes, for example, woody lignocelluloses such as hardwoods and conifers; herbaceous lignocelluloses (including palms and bamboos) such as switchgrass and cedar; cereals such as corn and rice, cassava, potatoes, etc. Examples include starch raw materials containing potatoes, and sugar raw materials containing sugarcane, sugar beet, molasses, etc., and biomass residues such as rice straw and bagasse after the production of these starches and sugars are also included. Also included are wood pulp, waste paper, building waste, municipal waste, pruning material, food waste and the like.
Aquatic plant biomass includes aquatic plants such as water hyacinth; seaweeds such as kombu and seaweed. Also included are chlorella and phytoplankton, which are plant microorganisms.
Animal biomass includes shrimp and crab shells and whey.

 バイオマスからのエタノール製造方法は、用いる原料の特性に応じて多少異なるが、基本的には前処理工程、糖化工程、発酵工程から構成でき、一般的にはさらに、濃縮(蒸留)工程及び脱水工程等を含む。発酵工程以外の工程は、場合によっては省略可能である。 The method for producing ethanol from biomass varies slightly depending on the characteristics of the raw materials used, but it can basically be composed of a pretreatment process, a saccharification process, and a fermentation process, and in general, a concentration (distillation) process and a dehydration process. Etc. Steps other than the fermentation step can be omitted in some cases.

 本発明の方法は、発酵工程を必須とするが、その他の工程は必要に応じて存在してもしなくてもよい。たとえば、本発明の方法は、必要に応じてそれぞれの原料に適した前処理工程を含むことができる。一般に、バイオマスは、産地から集荷され、使用に供されるまでの間、変質・分解を防ぐため、必要に応じて乾燥等の処理を施されて保存される。また、ほとんどの場合、集荷の後又はエタノールの製造直前等の時点で、バイオマスの粉砕工程が行われる。粉砕方法としては、必要に応じて乾式粉砕法又は湿式粉砕法が採用される。 The method of the present invention requires a fermentation process, but other processes may or may not be present as necessary. For example, the method of the present invention can include a pretreatment step suitable for each raw material as required. In general, biomass is stored after being collected from the production area and subjected to a treatment such as drying in order to prevent alteration and decomposition until it is used. In most cases, a biomass pulverization step is performed after collection or just before ethanol production. As the grinding method, a dry grinding method or a wet grinding method is adopted as necessary.

 糖質原料及び単糖類原料以外のバイオマスを原料として用いる場合、バイオマスを糖化する工程が必要となる。糖化工程は、一般に、酸処理、アルカリ処理、中性塩処理、水熱処理、酵素処理等を単独で又は組合せて実施される。 When using biomass other than saccharide raw materials and monosaccharide raw materials as raw materials, a process of saccharifying biomass is required. In general, the saccharification step is carried out by acid treatment, alkali treatment, neutral salt treatment, hydrothermal treatment, enzyme treatment or the like alone or in combination.

 たとえば、デンプン質原料を用いる場合、アミラーゼ及びプルラナーゼを用いてデンプンを液化及び糖化することができる。 For example, when starchy raw materials are used, starch can be liquefied and saccharified using amylase and pullulanase.

 リグノセルロース系バイオマスの前処理としては、濃硫酸処理(ピオリア法、ショルターニ・レオネ法、北海道法等)、希硫酸処理(ショーラー法、マジソン法、改良マジソン法、ソ連法、二段分解法等)、亜硫酸処理、濃塩酸処理(ペルギウス・ライナウ法、新ライナウ法等)、塩酸ガス処理(ブロードル法、ダルブオーフェン法、エラン法、野口研究所法等)等の酸分解、及び酵素による加水分解等が挙げられる。リグノセルロース系バイオマスの前処理のための酵素としては、セルラーゼ及びヘミセルラーゼ等が用いられる。糖化終了後、必要に応じて、用いた薬品及び不溶性バイオマス成分等を分離する。これらの処理により、単糖類、オリゴ糖、可溶化リグニン等を含有する糖化液が得られる。 As pretreatment of lignocellulosic biomass, concentrated sulfuric acid treatment (Peoria method, Scholtani-Leone method, Hokkaido method, etc.), dilute sulfuric acid treatment (Scholer method, Madison method, improved Madison method, Soviet method, two-stage decomposition method, etc.) , Acid decomposition such as sulfurous acid treatment, concentrated hydrochloric acid treatment (Pergius-Ryinau method, new Reinau method, etc.), hydrochloric acid gas treatment (Brodle method, Dalbuofen method, Elan method, Noguchi Laboratory method, etc.), and hydrolysis by enzymes Etc. Cellulases, hemicellulases, and the like are used as enzymes for pretreatment of lignocellulosic biomass. After completion of saccharification, the used chemicals and insoluble biomass components are separated as necessary. By these treatments, a saccharified solution containing monosaccharide, oligosaccharide, solubilized lignin and the like is obtained.

 これらの前処理法及び糖化法の詳細は、各種文献に記載されており、当業者は、使用する原料に応じて適宜設計及び選択することができる。 Details of these pretreatment methods and saccharification methods are described in various documents, and those skilled in the art can appropriately design and select according to the raw materials used.

 本発明の方法は、発酵工程を必須とする。発酵工程では、理論上、100gの糖質は約50gのエタノール及び約50gのCOになる(このとき、発酵歩合100%という。ここでいう糖質とはペントースやヘキソースをいう。)。発酵工程に供される材料は、上述のようなバイオマスそのもの(糖質原料、単糖類原料等)又は必要に応じて前処理工程及び/又は糖化工程を経て得られた糖化液である。これらの材料におけるペントース及び/又はヘキソースの含有率は、数%(W/V)から80%(W/V)以上に達するが、本発明に使用される材料としてはペントース及び/又はヘキソース含有率が比較的高いものが望ましい。さらに好ましくは、ペントース及び/又はヘキソースの含有率が10%(W/V)以上のものであり、最も好ましくは30%(W/V)以上のものである。なお、当初の含有率が10%(W/V)に満たないものは、濃縮して10%(W/V)以上として利用することも可能である。 The method of the present invention requires a fermentation process. In the fermentation process, theoretically, 100 g of saccharide becomes about 50 g of ethanol and about 50 g of CO 2 (in this case, the fermentation rate is 100%. Here, the saccharide refers to pentose and hexose). The material used for the fermentation process is the above-described biomass itself (a saccharide raw material, a monosaccharide raw material, etc.) or a saccharified liquid obtained through a pretreatment step and / or a saccharification step as necessary. The content of pentose and / or hexose in these materials reaches several percent (W / V) to 80% (W / V) or more, but the material used in the present invention is pentose and / or hexose content. A relatively high value is desirable. More preferably, the content of pentose and / or hexose is 10% (W / V) or more, and most preferably 30% (W / V) or more. If the initial content is less than 10% (W / V), it can be concentrated and used as 10% (W / V) or more.

 発酵工程は、pH4以上、特にpH5.5以上で好適に行うことができ、少なくともpH8までは良好に発酵が進行する。汚染防止、発酵歩合、他の工程との条件変更の少なさ等を勘案すると、pH5~7、特にpH5.5~6.5で行うことが有利である。 The fermentation process can be suitably performed at pH 4 or higher, particularly at pH 5.5 or higher, and fermentation proceeds well at least up to pH 8. Considering contamination prevention, fermentation rate, and a small change in conditions with other processes, it is advantageous to carry out at pH 5-7, especially at pH 5.5-6.5.

 また、温度条件は、20℃以上であればよく、40℃までは発酵工程を好適に行うことができる。発酵歩合、他の工程との条件変更の少なさ等を勘案すると、30℃~40℃、特に35℃~40℃で行うことが有利である。 Moreover, temperature conditions should just be 20 degreeC or more, and a fermentation process can be performed suitably to 40 degreeC. Considering the fermentation rate and the small change in conditions with other processes, it is advantageous to carry out the reaction at 30 ° C. to 40 ° C., particularly 35 ° C. to 40 ° C.

 したがって、発酵工程の最適pH及び温度条件は、pH5.5~6.5及び35~40℃である。反応時間は、一般に、6~72時間であるが、用いるバイオマス又は糖化液の特性等に応じて適宜選択することができる。本発明の方法によれば、一般に85~98%の高い発酵歩合を実現することができる。 Therefore, the optimum pH and temperature conditions for the fermentation process are pH 5.5 to 6.5 and 35 to 40 ° C. The reaction time is generally 6 to 72 hours, but can be appropriately selected according to the characteristics of the biomass or saccharified solution used. According to the method of the present invention, a high fermentation rate of generally 85 to 98% can be realized.

 発酵工程終了後、発酵液中には生産されたエタノールが含有されている。発酵工程で生産されたエタノールは、一般に、蒸留工程及び脱水工程を経て発酵液から回収・精製される。これらの工程の実施条件等については周知である。エタノールを含有する発酵液から、その後の付加的な工程、たとえば蒸留工程や脱水工程等、を経て得られる高純度に精製されたエタノールまでを、便宜上、包括的にエタノール含有溶液と総称する。 After the fermentation process, the fermented liquor contains the produced ethanol. Ethanol produced in the fermentation process is generally recovered and purified from the fermentation broth through a distillation process and a dehydration process. The implementation conditions of these steps are well known. From the fermentation liquid containing ethanol to the ethanol purified to high purity obtained through the subsequent additional steps, such as a distillation step and a dehydration step, are collectively referred to as an ethanol-containing solution for convenience.

 本発明の方法においては、発酵工程の後に、もろみの固液分離工程を行うことが好ましい。もろみの固液分離工程は公知であり、手法としては、たとえば、濾過(濾布、スクリーン、膜等)、遠心分離、デカンテーション等が挙げられる。
 このようなエタノール製造の各種工程については、たとえばBioresource Technology 98 (2007) 2415-2457等に記載されている。
In the method of the present invention, it is preferable to perform a mash solid-liquid separation step after the fermentation step. Moromi's solid-liquid separation step is known, and examples of the method include filtration (filter cloth, screen, membrane, etc.), centrifugation, decantation and the like.
Such various steps of ethanol production are described in, for example, Bioresource Technology 98 (2007) 241-2457.

 なお、ここで「精製エタノール」とは、日本薬局方による「エタノール」、すなわち15℃で95.1~95.6%(V/V)のエタノールを含有する水溶液を指す。これは、工業的には、酢酸エチルの製造等のための原料等として有用である。また、日本薬局方による「無水エタノール」は、15℃で99.5%(V/V)以上のエタノールを含有する水溶液であり、工業的には、燃料用等として使用される。 Here, “purified ethanol” refers to “ethanol” by the Japanese Pharmacopoeia, that is, an aqueous solution containing 95.1 to 95.6% (V / V) ethanol at 15 ° C. This is industrially useful as a raw material for the production of ethyl acetate and the like. “Anhydrous ethanol” according to the Japanese Pharmacopoeia is an aqueous solution containing 99.5% (V / V) or more of ethanol at 15 ° C., and is industrially used as a fuel.

 本発明の方法によって得られたエタノールは、燃料(石油代替エネルギー、ガソリン添加剤等)として使用できるほか、工業用原料(化学原料)、食品添加物等として使用することができ、また、食品(飲料も含む)、医薬品や衛生用品等の製造において使用することができる。 Ethanol obtained by the method of the present invention can be used as fuel (petroleum alternative energy, gasoline additive, etc.), industrial raw material (chemical raw material), food additive, etc. Can also be used in the manufacture of pharmaceuticals and hygiene products.

 ビタミンB2の回収
 本発明のエタノール製造方法を実施することにより、同時に発酵液中に大量のビタミンB2(リボフラビン)が産生される。KO11ΔP株から生産されたビタミンB2は、培養液中に溶けた状態でも溜まっていくが、生産量が多くなると結晶として培養液中に蓄積される。KO11ΔP株由来のビタミンB2含有培養液は、ビタミンB2結晶として医薬品原料や食品添加物や飼料添加物にしてもよいし、菌体を完全に滅菌後、そのまま飼料等に使うことができる。
Recovery of vitamin B2 By carrying out the ethanol production method of the present invention, a large amount of vitamin B2 (riboflavin) is simultaneously produced in the fermentation broth. Vitamin B2 produced from the KO11ΔP strain accumulates even when dissolved in the culture solution, but accumulates as crystals in the culture solution when the production amount increases. The culture solution containing vitamin B2 derived from the KO11ΔP strain may be used as a pharmaceutical raw material, a food additive, or a feed additive as vitamin B2 crystals, or can be used as it is for a feed or the like after the cells are completely sterilized.

 培養液中に結晶として蓄積されるビタミンB2は、一般的な精製法で回収及び精製が可能である。たとえば、培養液を加熱処理(60℃、30分)し、KO11ΔP株を滅菌した後、結晶画分を遠心分離し、沈殿物を回収する。この沈殿物を、さらに、DNAの分解(脱プリン化)のため、酸処理(塩酸又は硫酸約2%)し、約96%含量のビタミンB2を得る。これを酸溶媒でさらに結晶化し、約98%含量の製品を得ることが可能である。 Vitamin B2 accumulated as crystals in the culture solution can be recovered and purified by a general purification method. For example, the culture solution is heat-treated (60 ° C., 30 minutes) to sterilize the KO11ΔP strain, and then the crystal fraction is centrifuged to collect the precipitate. This precipitate is further acid-treated (hydrochloric acid or sulfuric acid about 2%) for DNA degradation (depurination) to obtain about 96% vitamin B2. It can be further crystallized with an acid solvent to obtain a product with a content of about 98%.

 1.KO11株の染色体上のptsGの破壊によるKO11ΔP株の作製
 (1) 相同組換え断片の作製
 相同組換え断片は、「Quick & Easy E. coli Gene Deletion kit」(商品名、Gene Bridges GmbH)のFRT-PGK-gb2-neo-FRTカセットを鋳型とし、PCR法でこのカセットの両末端に目的遺伝子であるptsG遺伝子(配列番号1)の相同配列(50base)を付加することにより作製した。相同配列(50base)は、(a)~(c)で示す3段階のPCR法で付加した。表1に、使用したプライマーの配列を掲載した。
1. Preparation of KO11ΔP strain by disruption of ptsG on the chromosome of KO11 strain (1) Preparation of homologous recombination fragment The homologous recombination fragment is FRT of “Quick & Easy E. coli Gene Deletion kit” (trade name, Gene Bridges GmbH). A PGK-gb2-neo-FRT cassette was used as a template, and a homologous sequence (50base) of the target gene ptsG gene (SEQ ID NO: 1) was added to both ends of this cassette by PCR. The homologous sequence (50base) was added by the three-step PCR method shown in (a) to (c). Table 1 lists the primer sequences used.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

 以下のものを使用した。
 ・10× KOD-plus-buffer (商品名「制限酵素・修飾酵素反応バッファーKOD-Plus-用Buffer(10×)」、Toyobo)
 ・MgSO (25mM; Toyobo)
 ・dNTPs (各10mM; Toyobo)
 ・KOD-plus-DNAポリメラーゼ(商品名「KOD-Plus-」、1unit/μL; Toyobo)
 ・FRT-PGK-gb2-neo-FRT PCRテンプレート(商品名「Quick & Easy E. coli Gene Deletion kit」、Gene Bridges GmbH)
 ・フォワードプライマー
  1回目: ptsG1 (P1)
  2回目: ptsG2 (P3)
  3回目: ptsG3 (P5)
 ・リバースプライマー
  1回目: ptsG1 (P2)
  2回目: ptsG2 (P4)
  3回目: ptsG3 (P6)
 ・6× Loading Dye: 25mg(0.25%)のブロモフェノールブルー(和光純薬)、25mg(0.25%)のキシレンシアノールFF(和光純薬)、3mL(3%)のグリセロール及び100μLの0.5M EDTA(和光純薬)、pH8.0(最終5mM)を混合後、蒸留水で全量を10mLとしたもの。
 ・サーマル・サイクラー (タカラバイオ株式会社)
The following were used.
・ 10x KOD-plus-buffer (trade name "Buffer for restriction enzyme / modification enzyme reaction buffer KOD-Plus- (10x)", Toyobo)
・ MgSO 4 (25 mM; Toyobo)
・ DNTPs (each 10 mM; Toyobo)
・ KOD-plus-DNA polymerase (trade name “KOD-Plus-”, 1 unit / μL; Toyobo)
FRT-PGK-gb2-neo-FRT PCR template (trade name “Quick & Easy E. coli Gene Deletion kit”, Gene Bridges GmbH)
-Forward primer 1st time: ptsG1 (P1)
Second time: ptsG2 (P3)
Third time: ptsG3 (P5)
・ Reverse primer 1st time: ptsG1 (P2)
Second time: ptsG2 (P4)
Third time: ptsG3 (P6)
6 × Loading Dye: 25 mg (0.25%) bromophenol blue (Wako Pure Chemicals), 25 mg (0.25%) xylene cyanol FF (Wako Pure Chemicals), 3 mL (3%) glycerol and 100 μL After mixing 0.5M EDTA (Wako Pure Chemical Industries, Ltd.) and pH 8.0 (final 5 mM), the total volume was made up to 10 mL with distilled water.
・ Thermal cycler (Takara Bio Inc.)

 (i) FRT-PGK-gb2-neo-FRTカセットへの相同配列の付加(1回目)
 200μL容PCRチューブに、31μLのMilli Q水、5μLの10× KOD-plus-buffer、2μLのMgSO、5μLのdNTPs、それぞれ2.5μLのプライマー〔ptsG1(P1)及びptsG1(P2)〕、及び鋳型として1.0μL(50ng)のFRT-PGK-gb2-neo-FRT PCRテンプレートを加え、最後に0.5μL(0.25U)のKOD-plus-DNAポリメラーゼを加えて、全量を50μLとした。この反応液をサーマル・サイクラーにセットした。94℃で2分間加温し、KOD-plus-DNAポリメラーゼを活性化した後、94℃で15秒間、55℃で30秒間、68℃で2分間の温度サイクルの反応を、30サイクル行った。
(I) Addition of homologous sequence to FRT-PGK-gb2-neo-FRT cassette (first time)
In a 200 μL PCR tube, add 31 μL Milli Q water, 5 μL 10 × KOD-plus-buffer, 2 μL MgSO 4 , 5 μL dNTPs, 2.5 μL primers [ptsG1 (P1) and ptsG1 (P2)], respectively 1.0 μL (50 ng) of FRT-PGK-gb2-neo-FRT PCR template was added as a template, and finally 0.5 μL (0.25 U) of KOD-plus-DNA polymerase was added to make a total volume of 50 μL. This reaction solution was set on a thermal cycler. After warming at 94 ° C. for 2 minutes to activate KOD-plus-DNA polymerase, 30 cycles of 94 ° C. for 15 seconds, 55 ° C. for 30 seconds, and 68 ° C. for 2 minutes were performed.

 このPCR反応液(5μL)に、1μLの6× Loading Dyeを混合した。この溶液6μLを用いて、1%TAEアガロース・ゲル上で60V、60分間の電気泳動を行った。このとき、増幅断片の位置を確認するための指標として、1kbpマーカーを同時に別のレーンで泳動した。 1 μL of 6 × Loading Dye was mixed with this PCR reaction solution (5 μL). Using 6 μL of this solution, electrophoresis was performed on a 1% TAE agarose gel at 60 V for 60 minutes. At this time, a 1 kbp marker was simultaneously run in another lane as an index for confirming the position of the amplified fragment.

 泳動後、サイバーセーフ染色液(商品名「サイバーセーフDNAゲル染色試薬(1×TAE)」、Invitrogen)にゲルを浸して、軽く攪拌しながら20分間染色を行った。紫外線を照射し、増幅断片のバンドを1662bp付近の位置に確認した。残りの45μLのPCR反応液を、CIA処理、エタノール沈澱、リンスをした。その後、減圧乾燥したペレットを、20μLのMilli Q水に溶解した。 After electrophoresis, the gel was immersed in a cyber-safe staining solution (trade name “Cyber-safe DNA gel staining reagent (1 × TAE)”, Invitrogen), and stained for 20 minutes while gently stirring. Ultraviolet light was irradiated, and the band of the amplified fragment was confirmed at a position near 1662 bp. The remaining 45 μL of the PCR reaction solution was subjected to CIA treatment, ethanol precipitation, and rinsing. Thereafter, the pellets dried under reduced pressure were dissolved in 20 μL of Milli Q water.

 (ii) FRT-PGK-gb2-neo-FRTカセットへの相同配列の付加(2回目)
 前記(i)で得られたPCR増幅断片を鋳型とし、プライマーとしてptsG2(P3)及びptsG2(P4)をそれぞれ用いて、(i)と同様の操作を繰り返した。
 (iii) FRT-PGK-gb2-neo-FRTカセットへの相同配列の付加 (3回目)
 前記(ii)で得られたPCR増幅断片を鋳型とし、プライマーとしてptsG3(P5)及びptsG3(P6)を用いて、(i)と同様の操作を繰り返した。
(Ii) Addition of homologous sequence to FRT-PGK-gb2-neo-FRT cassette (second time)
The same operation as in (i) was repeated using the PCR amplified fragment obtained in (i) above as a template and ptsG2 (P3) and ptsG2 (P4) as primers.
(Iii) Addition of homologous sequence to FRT-PGK-gb2-neo-FRT cassette (third time)
The same operation as in (i) was repeated using the PCR amplified fragment obtained in (ii) as a template and ptsG3 (P5) and ptsG3 (P6) as primers.

 (2) 相同組換え断片のゲル抽出
 以下のものを使用した。
 ・50×TAE: 2.0M Tris-HCl、20M 酢酸(和光純薬)、0.5M EDTA
 ・1×TAE: 50×TAEを蒸留水で50倍希釈した。
 ・1.0%アガロース・ゲル: アガロースS(ニッポンジーン)を1.0%(W/V)となるよう1×TAEバッファーに溶解した。
 ・サイバーセーフ染色液(前出、Invitrogen)
 ・QIAquick Gel Extraction Kit(商品名、Qiagen)
 ・前記(1)-(iii)で得たPCR増幅断片
(2) Gel extraction of homologous recombination fragments The following were used.
50 × TAE: 2.0M Tris-HCl, 20M acetic acid (Wako Pure Chemical Industries), 0.5M EDTA
1 × TAE: 50 × TAE was diluted 50 times with distilled water.
• 1.0% agarose gel: Agarose S (Nippon Gene) was dissolved in 1 × TAE buffer so as to be 1.0% (W / V).
・ Cyber-safe stain (supra, Invitrogen)
・ QIAquick Gel Extraction Kit (trade name, Qiagen)
-PCR amplified fragment obtained in (1)-(iii) above

 前記(1)-(iii)で得たPCR増幅断片(50μL)に、10μLの6× Loading Dyeを混合し、この溶液(60μL)を、1%TAEアガロース・ゲル上で60V、60分間の電気泳動を行った。このとき、抽出する増幅断片の位置を確認するための指標として、1kbpマーカーを同時に別のレーンで泳動した。泳動後、サイバーセーフ染色液にゲルを浸して軽く攪拌しながら20分間染色を行った。紫外線を照射し、増幅断片のバンドを1747bp付近の位置に確認し、そのバンドを含むゲルを回収した。回収した増幅断片を含むゲルを、「QIAquick Gel Extraction Kit」を用いてゲルより抽出した。以後、抽出した断片は、「ptsG相同組換え断片」とする。 The PCR-amplified fragment (50 μL) obtained in (1)-(iii) above was mixed with 10 μL of 6 × Loading Dye, and this solution (60 μL) was mixed on a 1% TAE agarose gel at 60 V for 60 minutes. Electrophoresis was performed. At this time, a 1 kbp marker was simultaneously run in another lane as an index for confirming the position of the amplified fragment to be extracted. After the electrophoresis, the gel was immersed in a cyber-safe staining solution and stained for 20 minutes with gentle stirring. The band of the amplified fragment was confirmed at a position near 1747 bp by irradiating with ultraviolet rays, and the gel containing the band was recovered. The gel containing the recovered amplified fragment was extracted from the gel using “QIAquick Gel Extraction Kit”. Hereinafter, the extracted fragment is referred to as “ ptsG homologous recombination fragment”.

 (3) KO11株染色体上の目的遺伝子への相同組換え
 前記(2)で抽出したptsG相同組換え断片を使用し、ptsG遺伝子の破壊を行った。相同組換えの効率を上げるために、Red/ET由来の組換え誘導タンパク質をKO11株内で発現させ、これがFRT-PGK-gb2-neo-FRTカセットに特異的に反応することを利用して相同組換えを誘導した。
(3) KO11 strain homologous recombination wherein to target gene on the chromosome using the ptsG homologous recombination fragment was extracted with (2), was disruption of ptsG gene. In order to increase the efficiency of homologous recombination, Red / ET-derived recombination-inducing protein is expressed in the KO11 strain and is homologous using the fact that it specifically reacts with the FRT-PGK-gb2-neo-FRT cassette. Recombination was induced.

 (i) KO11株へのRed/ETの導入
 以下のものを使用した。
 ・LB/Cm液体培地
 ・コンピテントセル: E.coli KO11株
 ・pRedET(amp)(20μg/μL) (Gene Bridges GmbH)
 ・エレクトロポレーション・キュベット (0.2cm; BIO-RAD)
 ・ジーン・パルサーII (BIO-RAD)
 ・パルス・コントローラー PLUS (BIO-RAD)
 ・LB液体培地
 ・LB/Amp,Cmプレート培地
(I) Introduction of Red / ET into KO11 strain The following were used.
LB / Cm liquid medium Competent cells: E. coli KO11 strain • pRedET (amp) (20 μg / μL) (Gene Bridges GmbH)
・ Electroporation cuvette (0.2cm; BIO-RAD)
・ Gene Pulsar II (BIO-RAD)
・ Pulse controller PLUS (BIO-RAD)
・ LB liquid medium ・ LB / Amp, Cm plate medium

 LB液体培地に、1.5%(W/V)寒天を加え、オートクレーブ滅菌した。60℃程度まで冷却した後、アンピシリン(和光純薬)を最終濃度100μg/mL及びクロラムフェニコールを最終濃度600μg/mLとなるように加え、シャーレに分注した。 To the LB liquid medium, 1.5% (W / V) agar was added and sterilized by autoclave. After cooling to about 60 ° C., ampicillin (Wako Pure Chemical Industries) was added to a final concentration of 100 μg / mL and chloramphenicol to a final concentration of 600 μg / mL, and dispensed into a petri dish.

 LB/Cm液体培地にKO11株を植菌し、濁度がOD 660≒0.6に達するまで37℃、60rpmの条件下で回転振とう培養した。この培養液1.4mLをチューブに移し、6,000rpmで5分間遠心分離した後、上清を捨て、残ったペレットを滅菌水1mLに再懸濁した。 The KO11 strain was inoculated into an LB / Cm liquid medium, and cultured with shaking at 37 ° C. and 60 rpm until the turbidity reached OD 660≈0.6. After transferring 1.4 mL of this culture solution to a tube and centrifuging at 6,000 rpm for 5 minutes, the supernatant was discarded, and the remaining pellet was resuspended in 1 mL of sterile water.

 この遠心分離、再懸濁の操作を計3回行うことにより菌体を洗浄し、最終的に滅菌水40μLに再懸濁した。これにpRed/ET (amp) 1μLを加えて混合し、エレクトロポレーション・キュベットに移した。ジーン・パルサーII及びパルス・コントローラー PLUSを用いて、電圧2.5kV、抵抗200Ω、静電容量25μFでエレクトロポレーションを行った後、直ちにLB液体培地400μLを加え、1.5mL容チューブに移し、30℃で1時間振とう培養(150rpm)した。培養液150μLをLB/Amp,Cmプレート培地に塗布し、30℃で16時間培養した。プレート上に生じたコロニーを、「KO11(Red/ET)」とし、プレートは4℃で保存した。 The centrifugation and resuspension operations were performed a total of three times to wash the cells, and finally resuspended in 40 μL of sterilized water. To this, 1 μL of pRed / ET (amp) was added and mixed, and transferred to an electroporation cuvette. After electroporation with Gene Pulser II and Pulse Controller PLUS at a voltage of 2.5 kV, a resistance of 200 Ω, and a capacitance of 25 μF, immediately add 400 μL of LB liquid medium and transfer to a 1.5 mL tube. The culture was shaken at 150 ° C. for 1 hour (150 rpm). 150 μL of the culture solution was applied to an LB / Amp, Cm plate medium and cultured at 30 ° C. for 16 hours. The colony formed on the plate was designated as “KO11 (Red / ET)”, and the plate was stored at 4 ° C.

 (ii) KO11株への相同組換え断片の導入及び相同組換えの誘導
 以下のものを使用した。
 ・LB/Cm液体培地
 ・10%(W/V)L-アラビノース: L-アラビノース(和光純薬)が10%(W/V)となるように蒸留水を加えた。
 ・ptsG相同組換え断片
 ・コンピテントセル: KO11(Red/ET)
 ・LB/kan,Cmプレート培地
(Ii) Introduction of homologous recombination fragment into KO11 strain and induction of homologous recombination The following were used.
LB / Cm liquid medium 10% (W / V) L-arabinose: Distilled water was added so that L-arabinose (Wako Pure Chemical Industries) was 10% (W / V).
-PtsG homologous recombination fragment-Competent cell: KO11 (Red / ET)
・ LB / kan, Cm plate medium

 LB液体培地に、1.5%(W/V)寒天を加え、オートクレーブ滅菌した。60℃程度まで冷却した後、カナマイシン硫酸塩(和光純薬)を最終濃度30μg/mL及びクロラムフェニコールを最終濃度600μg/mLとなるように加え、シャーレに分注した。 To the LB liquid medium, 1.5% (W / V) agar was added and sterilized by autoclave. After cooling to about 60 ° C., kanamycin sulfate (Wako Pure Chemical Industries) was added to a final concentration of 30 μg / mL and chloramphenicol to a final concentration of 600 μg / mL, and dispensed into a petri dish.

 LB/Cm液体培地にKO11(Red/ET)を植菌し、濁度がOD660≒0.3に達するまで、30℃、150rpmの条件下で振とう培養した。 KO11 (Red / ET) was inoculated into an LB / Cm liquid medium, and cultured under shaking at 30 ° C. and 150 rpm until the turbidity reached OD660≈0.3.

 Red/ET由来の組換えタンパク質によって組換えを誘導するため、10%(W/V)L-アラビノース50μLをそれぞれの試験管に植菌した。濁度がOD660≒0.6に達するまで、37℃、60rpmで回転振とう培養した後、前記(3)-(i)で示したエレクトロポレーション法でptsG相同組換え断片を1μL(100~400ng)を導入し、37℃で3時間振とう培養(60rpm)した。培養液150μLをLB/kan,Cmプレート培地に塗布し、37℃で16時間培養した。プレート上に生じたコロニーを形質転換体とし、プレートは4℃で保存した。 To induce recombination with the Red / ET-derived recombinant protein, 50 μL of 10% (W / V) L-arabinose was inoculated into each test tube. After culturing at 37 ° C. and 60 rpm until the turbidity reaches OD660≈0.6 , 1 μL (100 to 100 μg ) of ptsG homologous recombination fragment was obtained by the electroporation method described in (3)-(i) above. 400 ng) was introduced, followed by shaking culture (60 rpm) at 37 ° C. for 3 hours. 150 μL of the culture solution was applied to LB / kan, Cm plate medium and cultured at 37 ° C. for 16 hours. Colonies generated on the plate were used as transformants, and the plate was stored at 4 ° C.

 この相同組換えによって、ptsG遺伝子は、図7における下線部を付した小文字で示した断片(1068bp)が破壊される。図7において、大文字で示したのはプライマーP1、P3、P5の配列に相当する部分であり、下線を付した大文字で示したのはプライマーP2、P4、P6の配列に相当する部分である。 By this homologous recombination, the fragment (1068 bp) shown in lowercase letters with an underline in FIG. 7 is destroyed in the ptsG gene. In FIG. 7, the uppercase letters indicate the portions corresponding to the sequences of the primers P1, P3, and P5, and the underlined uppercase letters indicate the portions that correspond to the sequences of the primers P2, P4, and P6.

 (iii) コロニー・ダイレクトPCRによる相同組換え断片導入の確認
 以下のものを使用した。ptsG遺伝子の破壊を確認するため、プライマーには相同組換え断片の外側にアニールするプライマーを用いた。
 ・10× Reaction バッファー(BIOLINE)
 ・25mM dNTPs溶液(BIOLINE)
 ・50mM MgCl溶液(BIOLINE)
 ・HibriPolTM DNAポリメラーゼ(BIOLINE)
 ・フォワードプライマー: ptsG4(P7)
 ・リバースプライマー: ptsG4(P8)
 ・1.0%(W/V)アガロース・ゲル
 ・前記(3)-(ii)で得た形質転換体
(Iii) Confirmation of homologous recombination fragment introduction by colony direct PCR The following were used. In order to confirm the destruction of the ptsG gene, a primer that anneals to the outside of the homologous recombination fragment was used.
・ 10 × Reaction buffer (BIOLINE)
・ 25mM dNTPs solution (BIOLINE)
・ 50 mM MgCl 2 solution (BIOLINE)
・ HibriPol ™ DNA polymerase (BIOLINE)
-Forward primer: ptsG4 (P7)
・ Reverse primer: ptsG4 (P8)
1.0% (W / V) agarose gel Transformant obtained in (3)-(ii) above

 200μL容PCRチューブに2μLの10× Reactionバッファー 、2μLの25mM dNTPs溶液、1μLの50mM MgCl溶液、各1μLのフォワード及びリバースプライマー、12.9μLのMilli Q水を加え、最後に0.1μLのHibriPolTM DNAポリメラーゼを加えて全量20μLとした。 To a 200 μL PCR tube, add 2 μL of 10 × Reaction buffer, 2 μL of 25 mM dNTPs solution, 1 μL of 50 mM MgCl 2 solution, 1 μL of each forward and reverse primer, 12.9 μL of Milli Q water, and finally 0.1 μL of HibriPol ™. DNA polymerase was added to make a total volume of 20 μL.

 前記(3)-(ii)で得た形質転換体のホワイトコロニーを滅菌済み爪楊枝でつつき、反応液に鋳型として加えてPCR反応液を調製した。サーマル・サイクラーにセットし、94℃で5分間加温してHibriPolTM DNAポリメラーゼを活性化した後、変性を94℃で30秒間、アニーリングを55℃で30秒間、伸長反応を72℃で30秒間、この3段階を32サイクル行った。PCR終了後、1.0%(W/V)アガロース・ゲルで100V、30分間の電気泳動を行った。
 ptsG破壊株で1970bp付近に増幅を確認したクローンを「KO11ΔP」株とし、グリセロール・ストック(-84℃)した。
A white colony of the transformant obtained in the above (3)-(ii) was picked with a sterilized toothpick and added as a template to the reaction solution to prepare a PCR reaction solution. After setting in a thermal cycler and heating at 94 ° C. for 5 minutes to activate the HibriPol ™ DNA polymerase, denaturation at 94 ° C. for 30 seconds, annealing at 55 ° C. for 30 seconds, extension reaction at 72 ° C. for 30 seconds, These three stages were repeated 32 cycles. After completion of PCR, electrophoresis was carried out on a 1.0% (W / V) agarose gel at 100 V for 30 minutes.
A clone that was confirmed to be amplified in the vicinity of 1970 bp in the ptsG- disrupted strain was designated as “KO11ΔP” strain, which was glycerol stock (−84 ° C.).

 KO11ΔP株は、平成21年(2009年)1月26日に、独立行政法人産業技術総合研究所特許生物寄託センター(茨城県つくば市東1丁目1番地1 中央第6)に寄託され、受託番号FERM P-21758が付与された。また、平成22年(2010年)1月4日付でFERM BP-11221として「特許手続上の微生物の寄託等の国際的承認に関するブダペスト条約」下の国際寄託に移管され、受託された。 The KO11ΔP strain was deposited on January 26, 2009 at the National Institute of Advanced Industrial Science and Technology, Patent Biological Depositary Center (1st, 1st East, Tsukuba City, Ibaraki Prefecture, Central 6th), with accession number FERM P-21758 was given. In addition, on January 4, 2010, it was transferred to FERM BP-11221 and transferred to an international deposit under the “Budapest Convention on the International Approval of Deposits of Microorganisms in Patent Procedures”.

 2.組換え大腸菌KO11ΔP株における糖消費及びエタノール生産の評価
 リグノセルロース系バイオマスの糖化液中にはグルコース(6炭糖)及びキシロース(5炭糖)が多く含まれる。リグノセルロース系バイオマスの糖化液に対するKO11株及びKO11ΔP株の糖消費を評価することを目的に、グルコース及びキシロースを含むM9培地(M9混合糖培地)で発酵試験を行った。
2. Evaluation of Sugar Consumption and Ethanol Production in Recombinant Escherichia coli KO11ΔP Saccharified liquid of lignocellulosic biomass is rich in glucose (hexose) and xylose (pentose). For the purpose of evaluating the sugar consumption of the KO11 strain and KO11ΔP strain with respect to the lignocellulosic biomass saccharified solution, a fermentation test was conducted in an M9 medium (M9 mixed sugar medium) containing glucose and xylose.

 (1) 培地調製
 以下のものを使用した。
  ・グルコース (和光純薬)
  ・キシロース (和光純薬)
  ・20× M9塩類: NHCl(和光純薬) 20g/L、KHPO(和光純薬) 60g/L、NaHPO(和光純薬) 120g/L、NaCl(和光純薬) 10g/Lとなるように蒸留水に溶解し、オートクレーブ滅菌(120℃、15分間)したものを用いた。
  ・カザミノ酸 (日本製薬)
  ・MgSO (和光純薬)
  ・1Mリン酸緩衝液: 1MのNaHPO・12HO(和光純薬)溶液に、30℃でpH6.7となるまで1MのKHPO溶液を添加し、オートクレーブ滅菌したものを用いた。
(1) Medium preparation The following were used.
・ Glucose (Wako Pure Chemical Industries)
・ Xylose (Wako Pure Chemical Industries)
・ 20 × M9 salts: NH 4 Cl (Wako Pure Chemical) 20 g / L, KH 2 PO 4 (Wako Pure Chemical) 60 g / L, NaHPO 4 (Wako Pure Chemical) 120 g / L, NaCl (Wako Pure Chemical) 10 g / L L was dissolved in distilled water so as to be L, and autoclaved (120 ° C., 15 minutes).
・ Casamino acid (Nippon Pharmaceutical)
・ MgSO 4 (Wako Pure Chemical Industries)
1M phosphate buffer solution: 1M Na 2 HPO 4 · 12H 2 O (Wako Pure Chemical Industries) solution, 1M KH 2 PO 4 solution added at 30 ° C. until pH 6.7, and autoclaved Using.

 M9混合糖培地は、以下のようにして調製した。4.8gのグルコースと3.2gのキシロースを含む水溶液58.2mLを加えた100mL三角フラスコをオートクレーブ滅菌した。この100mL容三角フラスコに、20× M9塩類 4mL、100mM MgSO 0.8mL、1Mリン酸緩衝液 16mL、20%(W/V)カザミノ酸 1mLを加えて全量を80mLとし、グルコース及びキシロースの最終濃度をそれぞれ6%(W/V)と4%(W/V)とした培地を、M9混合糖培地とした。 The M9 mixed sugar medium was prepared as follows. A 100 mL Erlenmeyer flask to which 58.2 mL of an aqueous solution containing 4.8 g of glucose and 3.2 g of xylose was added was autoclaved. To this 100 mL Erlenmeyer flask, add 4 mL of 20 × M9 salts, 0.8 mL of 100 mM MgSO 4 , 16 mL of 1M phosphate buffer, and 1 mL of 20% (W / V) casamino acid to make a total volume of 80 mL. Medium with concentrations of 6% (W / V) and 4% (W / V), respectively, was designated as M9 mixed sugar medium.

 (2) 発酵試験
 以下のものを使用した。
・KO11株、KO11ΔP株: グリセロール・ストック(30%(W/V))したものを使用した。
・LB液体培地: 1%(W/V)NaCl、1%(W/V)BactoTM Peptone(日本ベクトン・ディッキンソン)、0.5%(W/V) イースト・エキストラクト(日本製薬)、1.5%寒天(和光純薬)となるように蒸留水に溶解し、オートクレーブ滅菌をした。
・LB/Cmプレート: LB液体培地に、1.5%(W/V)寒天を加え、オートクレーブ滅菌した。60℃程度まで冷却した後、クロラムフェニコール(和光純薬)を最終濃度600μMとなるように加え、シャーレに分注した。
 ・LB/Cm液体培地: LB液体培地5mLをオートクレーブ後、クロラムフェニコールを最終濃度600μg/mLとなるように加えた。
 ・M9混合糖培地
 ・濃硫酸(和光純薬)
 ・インキュベーター(東京理化器械株式会社)
 ・爪楊枝: 100mL容ビーカーに入れ、オートクレーブ滅菌した。
(2) Fermentation test The following were used.
KO11 strain, KO11ΔP strain: Glycerol stock (30% (W / V)) was used.
LB liquid medium: 1% (W / V) NaCl, 1% (W / V) Bacto ™ Peptone (Nippon Becton Dickinson), 0.5% (W / V) East Extract (Nippon Pharmaceutical), It was dissolved in distilled water so as to be 5% agar (Wako Pure Chemical Industries), and sterilized by autoclave.
LB / Cm plate: 1.5% (W / V) agar was added to the LB liquid medium, and autoclaved. After cooling to about 60 ° C., chloramphenicol (Wako Pure Chemical Industries) was added to a final concentration of 600 μM and dispensed into a petri dish.
LB / Cm liquid medium: After autoclaving 5 mL of LB liquid medium, chloramphenicol was added to a final concentration of 600 μg / mL.
・ M9 mixed sugar medium ・ Concentrated sulfuric acid (Wako Pure Chemical Industries)
・ Incubator (Tokyo Rika Kikai Co., Ltd.)
-Toothpick: Placed in a 100 mL beaker and sterilized by autoclave.

 クリーンベンチ内でLB/Cmプレート(KO11ΔP株の場合はLB/Cm,Kmプレートを使用)に爪楊枝を用いてKO11株及びKO11ΔP株を画線し、37℃で16時間静置培養した。その後、クリーンベンチ内でLB/Cm液体培地5mLにシングルコロニーを植菌し、37℃、60rpmの条件下で16時間回転振とう培養した。さらに、培養液100μLをクリーンベンチ内でLB液体培地100mLに植菌し、30℃、150rpmの条件下で16時間振とう培養した。この培養液を前培養液とした。 In a clean bench, the KO11 strain and the KO11ΔP strain were streaked using a toothpick on an LB / Cm plate (LB / Cm and Km plates were used in the case of the KO11ΔP strain), and then statically cultured at 37 ° C. for 16 hours. Thereafter, a single colony was inoculated into 5 mL of LB / Cm liquid medium in a clean bench, and cultured with shaking at 37 ° C. and 60 rpm for 16 hours. Furthermore, 100 μL of the culture solution was inoculated into 100 mL of LB liquid medium in a clean bench, and cultured with shaking at 30 ° C. and 150 rpm for 16 hours. This culture solution was used as a preculture solution.

 前培養液40mLを50mL容滅菌チューブへ分注し、25℃、6,000´Gの条件下で10分間遠心分離した。上清をデカンテーションで捨て、電子天秤で菌体の湿重量を測定した。測定後、乾燥重量が1g/Lとなるように、M9混合糖培地に植菌し、発酵栓をした。また、発酵栓には10mLメスピペットを用いて濃硫酸を2mL程度加えた。この状態で、インキュベーターを用いて30℃、150rpmの条件下で8日間発酵試験を行った。 40 mL of the preculture was dispensed into a 50 mL sterilized tube and centrifuged at 25 ° C. and 6,000′G for 10 minutes. The supernatant was discarded by decantation, and the wet weight of the cells was measured with an electronic balance. After the measurement, M9 mixed sugar medium was inoculated so as to have a dry weight of 1 g / L, and a fermentation stopper was applied. Further, about 2 mL of concentrated sulfuric acid was added to the fermentation stopper using a 10 mL measuring pipette. In this state, a fermentation test was conducted for 8 days under the conditions of 30 ° C. and 150 rpm using an incubator.

 (3) HPLCによる培地糖濃度分析
 以下のものを使用した。
 ・グルコース
 ・キシロース
 ・アセトニトリル(和光純薬)
 ・HPLC装置
 デガッサー DGU-12(SHIMADZU)
 カラムオーブン CTO-10ASvp(SHIMADZU)
 検出器 RID-10A(SHIMADZU)
 クロマトパック C-R6A(SHIMADZU)
 システムコントローラー SCL-10Avp(SHIMADZU)
 オートサンプラー SIL-20A(SHIMADZU)
 デュアルポンプ LC-10AD(SHIMADZU)
 ・分析条件
 カラム Wakosil 5NH2 直径4.0mm、長さ150mm(Wakopak(登録商標)、和光純薬)
 溶媒 アセトニトリル:水=80:20(v/v)
 カラム温度 40℃
 流速 1mL/min
(3) Medium sugar concentration analysis by HPLC The following were used.
・ Glucose ・ Xylose ・ Acetonitrile (Wako Pure Chemical Industries)
・ HPLC equipment Degasser DGU-12 (SHIMADZU)
Column oven CTO-10ASvp (SHIMADZU)
Detector RID-10A (SHIMADZU)
Chromatopack C-R6A (SHIMADZU)
System controller SCL-10Avp (SHIMADZU)
Autosampler SIL-20A (SHIMADZU)
Dual pump LC-10AD (SHIMADZU)
Analysis conditions Column Wakosil 5NH2 Diameter 4.0 mm, Length 150 mm (Wakopak (registered trademark), Wako Pure Chemical Industries)
Solvent acetonitrile: water = 80: 20 (v / v)
Column temperature 40 ° C
Flow rate 1mL / min

 サンプリングで回収した培養液上清600μLをマイクロシリンジでフィルター滅菌したものを、液体クロマトグラフィー用試料とした。また、0、2、4、6、8、10%(W/V)の各濃度のグルコース溶液及びキシロース溶液をスタンダードとして用いた。 A sample for liquid chromatography was prepared by sterilizing 600 μL of the culture supernatant collected by sampling with a microsyringe. In addition, glucose solutions and xylose solutions having concentrations of 0, 2, 4, 6, 8, and 10% (W / V) were used as standards.

 オートサンプラーSIL-20Aを用いて、各試料10μLをデュアルポンプLC-10AD内に注入し、クロマトパックCR-6Aで検出したピーク面積の比から培養液上清中の糖濃度を算出した。 Using an autosampler SIL-20A, 10 μL of each sample was injected into the dual pump LC-10AD, and the sugar concentration in the culture supernatant was calculated from the ratio of peak areas detected by Chromatopack CR-6A.

(4) GCによるエタノール濃度分析
 以下のものを使用した。
 ・イソプロピルアルコール(和光純薬)
 ・エタノール(和光純薬)
 ・GC装置
 ガスクロマトグラフ GC-2014(SHIMADZU)
 クロマトパック C-R6A
 検出器 FID-2014 (SHIMADZU)
 ・分析条件
 カラム温度 150℃
 検出器温度 250℃
 気化室温度 250℃
 カラム 液相 5% Therrmon 1000(商品名;信和化工株式会社)
 担体 Sunpak-A 直径3.2mm、長さ2.1m(商品名;信和化工株式会社)
 流速 60mL/min
 キャリアガス N
(4) Analysis of ethanol concentration by GC The following were used.
・ Isopropyl alcohol (Wako Pure Chemical Industries)
・ Ethanol (Wako Pure Chemical Industries)
・ GC system Gas chromatograph GC-2014 (SHIMADZU)
Chromatopack C-R6A
Detector FID-2014 (SHIMADZU)
・ Analysis conditions Column temperature 150 ℃
Detector temperature 250 ° C
Vaporization chamber temperature 250 ℃
Column Liquid phase 5% Thermon 1000 (trade name; Shinwa Kako Co., Ltd.)
Carrier Sunpak-A Diameter 3.2mm, Length 2.1m (Trade name; Shinwa Kako Co., Ltd.)
Flow rate 60mL / min
Carrier gas N 2

 サンプリングで回収した培養液上清300μLと等量の5%(v/v)イソプロピルアルコール(内部標準物質)とを混合し、ガスクロマトグラフィー用試料とした。また、5%(v/v)イソプロピルアルコールと0、2、4、6、8、10%(v/v)の各濃度のエタノール溶液とをそれぞれ等量混合し、スタンダードとした。 300 μL of the culture supernatant collected by sampling and an equal amount of 5% (v / v) isopropyl alcohol (internal standard substance) were mixed to obtain a sample for gas chromatography. Further, 5% (v / v) isopropyl alcohol and 0, 2, 4, 6, 8, 10% (v / v) ethanol solutions of equal concentration were mixed in equal amounts to obtain a standard.

 各試料5μLをガスクロマトグラフGC-2014に注入し、クロマトパックCR-6Aで検出したピーク面積の比から培養液上清中のエタノール濃度を算出した。 5 μL of each sample was injected into the gas chromatograph GC-2014, and the ethanol concentration in the culture supernatant was calculated from the ratio of the peak areas detected by Chromatopack CR-6A.

 結果を図1~3に示す。
 図1は、KO11株及びKO11ΔP株のM9糖混合培地での培養におけるキシロース濃度の変化を示す。グルコース及びキシロース共存下において、KO11株(白丸;○)はほとんどキシロースを利用しないのに対して、KO11ΔP株(黒正方形;■)はキシロースを利用することができることが分かった。
 培養3日目のキシロースの消費量を比較すると、KO11株は初発キシロース濃度の16%を消費したのに対して、KO11ΔP株は55%を消費した。すなわち、KO11ΔP株のキシロース消費量はKO11株の3倍以上であり、KO11ΔP株はグルコースの消費を抑制しグルコースの共存下においてキシロースを効率よく消費することが判明した。
The results are shown in FIGS.
FIG. 1 shows the change in xylose concentration in the culture of the KO11 strain and the KO11ΔP strain in an M9 sugar mixed medium. In the presence of glucose and xylose, the KO11 strain (white circle; ◯) hardly used xylose, whereas the KO11ΔP strain (black square; ■) was able to use xylose.
Comparing the consumption of xylose on the third day of culture, KO11 strain consumed 16% of the initial xylose concentration, whereas KO11ΔP strain consumed 55%. That is, it was found that the xylose consumption of the KO11ΔP strain is three times or more that of the KO11 strain, and the KO11ΔP strain suppresses glucose consumption and efficiently consumes xylose in the presence of glucose.

 図2は、KO11株及びKO11ΔP株のM9糖混合培地での培養におけるグルコース濃度の変化を示す。培養3日目で、KO11株(白丸;○)は初発グルコース濃度の97%を消費したが、KO11ΔP株(黒正方形;■)は43%の消費量を示しており、ptsG遺伝子を破壊することでグルコース消費が抑制されることが判明した。 FIG. 2 shows the change in glucose concentration in the culture of the KO11 strain and the KO11ΔP strain in an M9 sugar mixed medium. On the third day of culture, KO11 strain (white circle; ○) consumed 97% of the initial glucose concentration, while KO11ΔP strain (black square; ■) showed 43% consumption, destroying the ptsG gene. It was found that glucose consumption was suppressed.

 図3は、KO11株及びKO11ΔP株のM9糖混合培地での培養におけるエタノール濃度の変化を示す。KO11ΔP株(黒正方形;■)は、KO11株(白丸;○)と比較してエタノール生産速度がやや劣るが生産量が多く、0.8%も多くエタノールを生産することが分かった。 FIG. 3 shows the change in ethanol concentration in the culture of the KO11 strain and KO11ΔP strain in the M9 sugar mixed medium. It was found that the KO11ΔP strain (black square; ■) produced ethanol with a production rate of 0.8%, although the ethanol production rate was slightly inferior to that of the KO11 strain (white circle; ○).

 3.ジャーファーメンターでのエタノール発酵試験
 大腸菌KO11株及びKO11ΔP株を用いて、ジャーファーメンターでの発酵試験を行った。
3. Ethanol fermentation test with jar fermenter Fermentation test with jar fermenter was performed using Escherichia coli KO11 strain and KO11ΔP strain.

 以下のものを使用した。
・YPD培地(Difco社製、Lot No. 7242780)
・グルコース(和光純薬工業株式会社製、特級、Lot No. ALP4694)
・キシロース(和光純薬工業株式会社製、特級、Lot No. PEH5709)
・99.5%エタノール(関東化学社製、特級、Lot No. 002XI222)
・回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L(24)型)
・回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L型)
・高速冷却遠心機(株式会社久保田製作所製、モデル6500型)
・遠心機(TOMY社製、モデルMX-305型)
・ジャーファーメンター(株式会社高杉製作所製、モデルTS-M5L型)
The following were used.
YPD medium (Difco, Lot No. 7242780)
・ Glucose (Wako Pure Chemical Industries, special grade, Lot No. ALP4694)
・ Xylose (Wako Pure Chemical Industries, special grade, Lot No. PEH5709)
・ 99.5% ethanol (Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222)
・ Rotary shake incubator (Takasugi Mfg. Co., Ltd., model TS-RS12L (24))
・ Rotary shake incubator (Takasugi Seisakusho, Model TS-RS12L)
・ High-speed cooling centrifuge (Model Kubota, Model 6500)
・ Centrifuge (TOMY model MX-305)
・ Jar Fermenter (Model Takasugi Seisakusho, Model TS-M5L)

 (1) 菌体の調製
 培養には、YPD培地(Difco社製、Lot No. 7242780;3%(W/V)グルコースを含有)にキシロース(和光純薬工業株式会社製、特級、Lot No. PEH5709)を3%(W/V)になるように添加して調製したグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地を使用した。
(1) Preparation of bacterial cells For cultivation, YPD medium (manufactured by Difco, Lot No. 7242780; containing 3% (W / V) glucose) and xylose (manufactured by Wako Pure Chemical Industries, Ltd., special grade, Lot No. YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding PEH5709) to 3% (W / V) was used.

 500mL容の三角フラスコに前述のグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地100mLを分注し、寒天培地から各株の1コロニーを無菌的に接種した。三角フラスコの蓋にはアルミキャップを使用した。回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L(24)型)を使用して、37℃、120rpmで28時間培養した。 In a 500 mL Erlenmeyer flask, 100 mL of the aforementioned YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) was dispensed, and one colony of each strain was aseptically inoculated from the agar medium. An aluminum cap was used for the lid of the Erlenmeyer flask. Using a rotary shaking incubator (Model TS-RS12L (24), manufactured by Takasugi Seisakusho Co., Ltd.), the cells were cultured at 37 ° C. and 120 rpm for 28 hours.

 培養液を高速冷却遠心機(株式会社久保田製作所製、モデル6500型)で5,000rpm、5分間遠心処理して菌体と培地とを分離した。得られた菌体ペレットを生理食塩水で洗浄し、発酵試験に用いた。 The culture solution was centrifuged at 5,000 rpm for 5 minutes in a high-speed cooling centrifuge (model 6500, manufactured by Kubota Corporation) to separate the cells and the medium. The obtained cell pellet was washed with physiological saline and used for a fermentation test.

 (2) ジャー培養発酵試験
 発酵試験の基質として、グルコース 7%(W/V)(和光純薬工業株式会社製、特級、Lot No. ALP4694)、キシロース 3%(W/V)(和光純薬工業株式会社製、特級、Lot No. PEH5709)となるようにグルコース及びキシロースを蒸留水に溶解し、ジャーファーメンター付属ガラス発酵槽(株式会社高杉製作所製、モデルTS-101)にこの培地1000mLを入れて、121℃、15分間オートクレーブ滅菌した。オートクレーブ終了後、窒素源としてYPD培地(Difco社製、Lot No. 7242780;3%(W/V)グルコースを含有)を5g添加した。
(2) Jar culture fermentation test Glucose 7% (W / V) (Wako Pure Chemical Industries, Special grade, Lot No. ALP4694), Xylose 3% (W / V) (Wako Pure Chemical) Glucose and xylose were dissolved in distilled water so that it would be made by Kogyo Co., Ltd., special grade, Lot No. PEH5709), and 1000 mL of this medium was added to a jar fermenter-attached glass fermenter (Takasugi Seisakusho, Model TS-101) Then, autoclaved at 121 ° C. for 15 minutes. After completion of the autoclave, 5 g of YPD medium (Difco, Lot No. 7242780; containing 3% (W / V) glucose) was added as a nitrogen source.

 前培養で得た菌体ペレットを湿重量で850mg回収し、全量ジャーファーメンター内の培地に植菌した。その後37℃、180rpmにて好気状態で培養し、pHをpH5.5~6.0の範囲にNaOHにて自動制御した。培養開始から134時間、連続で培養した。適当な時間にサンプリングを行った。サンプリングした培養液を8,000rpm、5分間遠心処理し、以下の方法でエタノール濃度及び利用されなかった残糖(グルコース及びキシロース)濃度を測定した。 850 mg of the bacterial cell pellet obtained in the pre-culture was collected by wet weight, and the whole amount was inoculated into the medium in the jar fermenter. Thereafter, the cells were cultured in an aerobic state at 37 ° C. and 180 rpm, and the pH was automatically controlled in the pH range of 5.5 to 6.0 with NaOH. The cells were continuously cultured for 134 hours from the start of the culture. Sampling was performed at an appropriate time. The sampled culture solution was centrifuged at 8,000 rpm for 5 minutes, and the ethanol concentration and the residual sugar (glucose and xylose) concentrations that were not used were measured by the following method.

 エタノールの測定は、検体のエタノール濃度が0.2~1.0%(V/V)の範囲内になるよう試料を1~20倍希釈し、エタノール分析用ガスクロマトグラフ装置(GL Sciences社製)に供して分離定量した(カラムは「Porapak Type R」(商品名;Waters社製)カラムを使用、キャリアーガスは窒素、流速60mL/min)。別途、エタノール(関東化学社製、特級、Lot No. 002XI222)を同じ条件で分離し、測定面積とエタノールの重量とが直線性に優れた標準曲線となる条件を設定した。内部標準にはイソプロパノールを使用し、内部標準に対するエタノールの一次回帰分析から換算係数を求めた。 For the measurement of ethanol, the sample is diluted 1 to 20 times so that the ethanol concentration in the sample is within the range of 0.2 to 1.0% (V / V), and the gas chromatograph for ethanol analysis (GL Sciences) (The column is “Porapak Type R” (trade name; manufactured by Waters) column, the carrier gas is nitrogen, and the flow rate is 60 mL / min). Separately, ethanol (manufactured by Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222) was separated under the same conditions, and conditions were set so that the measurement area and the weight of ethanol were standard curves with excellent linearity. Isopropanol was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of ethanol with respect to the internal standard.

 糖濃度の測定は、検体の糖濃度が10~300ppmの範囲内になるよう試料を10~100倍希釈し、糖分析用イオンカラムクロマトグラフ装置(DIONEX社製)に供して分離定量した。使用したカラムはPA-1(商品名;DIONEX社製)であり、溶出は水のみで1mL/minの速度で行った。溶出糖の定量のため、別途、5種の単糖(グルコース、マンノース、ガラクトース、キシロース、アラビノース)を同じ条件で分離し、測定面積と各糖の重量が直線性に優れた標準曲線の得られる条件を設定した。内部標準としてデオキシグルコースを用い、内部標準に対する各糖の一次回帰分析から換算係数を求めた。得られた各糖の換算係数と前記測定された面積から、試料に含まれる単糖の含量を算出した。 For the measurement of sugar concentration, the sample was diluted 10 to 100 times so that the sugar concentration of the sample was in the range of 10 to 300 ppm, and subjected to separation and quantification using an ion column chromatograph for sugar analysis (DIONEX). The column used was PA-1 (trade name; manufactured by DIONEX), and elution was performed with water alone at a rate of 1 mL / min. Separately, 5 types of monosaccharides (glucose, mannose, galactose, xylose, arabinose) are separated under the same conditions for quantification of eluted sugars, and a standard curve with excellent linearity in the measurement area and the weight of each sugar is obtained. A condition was set. Deoxyglucose was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of each sugar relative to the internal standard. The content of monosaccharide contained in the sample was calculated from the conversion factor of each obtained sugar and the measured area.

 結果を図4に示す。図からわかるように、KO11ΔP株(「ΔP」と表示;黒正方形;■)は、好気的な条件下でも最終的なエタノール濃度(パネル(A))が4.59%にまで達し、この時の残糖(パネル(B))はグルコース(「グルコースΔP」と表示;白三角;△)が1.02%、キシロース(「キシロースΔP」と表示;白丸;○)が0.59%であった。一方、KO11株(白丸;○)は、最終的なエタノール濃度(パネル(A))が3.77%、この時の残糖(パネル(B))はグルコース(「グルコース KO11」と表示;黒菱形;◆)が0.01%であり、キシロース(「キシロース KO11」と表示;黒正方形;■)が2.21%であった。したがって、KO11株に比べてKO11ΔP株の方が最終的なエタノール生産量が多いことが分かる。 The results are shown in FIG. As can be seen from the figure, the KO11ΔP strain (labeled “ΔP”; black square; ■) has a final ethanol concentration (panel (A)) of 4.59% even under aerobic conditions. Residual sugar at the time (panel (B)) is 1.02% for glucose (displayed as “glucose ΔP”; white triangle; Δ), and 0.59% for xylose (displayed as “xylose ΔP”; white circle; ○) there were. On the other hand, KO11 strain (white circle; ○) has a final ethanol concentration (panel (A)) of 3.77%, and residual sugar (panel (B)) at this time is indicated by glucose (“glucose KO11”; black) The diamond shape (♦) was 0.01%, and the xylose (labeled “xylose KO11”; black square; ■) was 2.21%. Therefore, it can be seen that the final ethanol production is higher in the KO11ΔP strain than in the KO11 strain.

 4.組換え大腸菌KO11ΔP株の細胞堅牢性の評価
 大腸菌KO11ΔP株及びKO11株を用いて、各株の菌体の堅牢性を比較した。
4). Evaluation of cell robustness of recombinant Escherichia coli KO11ΔP strain Using the Escherichia coli KO11ΔP strain and KO11 strain, the robustness of the cells of each strain was compared.

 (1) 菌体の調製
 培養には、YPD培地(Difco社製、Lot No. 7242780;3%(W/V)グルコースを含有)にキシロース(和光純薬工業株式会社製、特級、Lot No. PEH5709)3%(W/V)を添加して調製したグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地を使用した。
(1) Preparation of bacterial cells For cultivation, YPD medium (manufactured by Difco, Lot No. 7242780; containing 3% (W / V) glucose) and xylose (manufactured by Wako Pure Chemical Industries, Ltd., special grade, Lot No. PEH5709) YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding 3% (W / V) was used.

 500mL容の三角フラスコに前述のグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地100mLを分注し、寒天培地から1コロニーを無菌的に接種した。三角フラスコの蓋にはアルミキャップを使用した。回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L(24)型)を使用して、37℃、120rpmで20時間培養した。 In a 500 mL Erlenmeyer flask, 100 mL of the aforementioned YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) was dispensed, and one colony was aseptically inoculated from the agar medium. An aluminum cap was used for the lid of the Erlenmeyer flask. Using a rotary shake incubator (Model TS-RS12L (24), manufactured by Takasugi Seisakusho Co., Ltd.), the cells were cultured at 37 ° C. and 120 rpm for 20 hours.

 培養液を高速冷却遠心機(株式会社久保田製作所製、モデル6500型)で5,000rpm、5分間遠心処理して、菌体と培地とを分離した。得られた菌体ペレットを生理食塩水で洗浄し、発酵試験に用いた。 The culture solution was centrifuged at 5,000 rpm for 5 minutes in a high-speed cooling centrifuge (model 6500, manufactured by Kubota Corporation) to separate the cells and the medium. The obtained cell pellet was washed with physiological saline and used for a fermentation test.

 (2) 繰り返し発酵試験
 発酵試験の基質として、グルコース 2%(W/V)(和光純薬工業株式会社製、特級、Lot No. ALP4694)、キシロース 2%(W/V)(和光純薬工業株式会社製、特級、Lot No. PEH5709)となるようにグルコース及びキシロースを蒸留水に溶解し、孔径0.2μmのメンブレン(NALGENE社製 ボトルトップフィルターフィルター)でろ過した混合糖液を使用した。
(2) Repeated fermentation test As substrate for fermentation test, glucose 2% (W / V) (manufactured by Wako Pure Chemical Industries, special grade, Lot No. ALP4694), xylose 2% (W / V) (Wako Pure Chemical Industries) Glucose and xylose were dissolved in distilled water so as to be a special grade, Lot No. PEH5709, and a mixed sugar solution filtered through a membrane having a pore size of 0.2 μm (NALGENE bottle top filter filter) was used.

 50mL容のポリプロピレン製遠沈管(CORNING社製)にグルコース2%(W/V)・キシロース2%(W/V)混合糖液を20mL入れ、湿重量で1.1g(乾燥菌体重量換算で糖液に対し1%(W/V))の前述の菌体を分散させた。回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L型)を使用し、37℃、120rpmの条件で24時間を1サイクルとして培養した。 20 mL of glucose 2% (W / V) / xylose 2% (W / V) mixed sugar solution is placed in a 50 mL polypropylene centrifuge tube (CORNING), and 1.1 g wet weight (in terms of dry cell weight) 1% (W / V)) of the aforementioned microbial cells was dispersed in the sugar solution. Using a rotary shaking incubator (Model TS-RS12L, manufactured by Takasugi Seisakusho Co., Ltd.), the culture was performed at 37 ° C. and 120 rpm for 24 hours as one cycle.

 1サイクル終了後に、遠心機(TOMY社製、モデルMX-305型)を使用し、5,000rpm、5分間の遠心処理をして上清と菌体とを分離した。菌体を再度5,000rpm、1分間遠心処理して完全に液体を除いた後、湿菌体重量を測定した。この菌体を、新たな混合糖液20mLに再び分散し、次のサイクルの発酵をおこなった。これを合計4回繰り返した。 After completion of one cycle, the supernatant and the cells were separated by centrifugation at 5,000 rpm for 5 minutes using a centrifuge (Model MX-305, manufactured by TOMY). The cells were centrifuged again at 5,000 rpm for 1 minute to completely remove the liquid, and then the wet cell weight was measured. The cells were again dispersed in 20 mL of a new mixed sugar solution, and the next cycle of fermentation was performed. This was repeated a total of 4 times.

 各サイクル終了後に採取した上清は、さらに8,000rpm、5分間遠心処理し、エタノール、グルコース及びキシロースの濃度を測定した。 The supernatant collected after each cycle was further centrifuged at 8,000 rpm for 5 minutes, and the concentrations of ethanol, glucose and xylose were measured.

 エタノールの測定は、検体のエタノール濃度が0.2~1.0%(V/V)の範囲内になるよう試料を1~20倍希釈し、エタノール分析用ガスクロマトグラフ装置(GL Sciences社製)に供して分離定量した(「Porapak Type R」(商品名;Waters社製)カラムを使用、キャリアーガスは窒素、流速60mL/min)。別途、エタノール(関東化学社製、特級、Lot No. 002XI222)を同じ条件で分離し、測定面積とエタノールの重量とが直線性に優れた標準曲線となる条件を設定した。内部標準にはイソプロパノールを使用し、内部標準に対するエタノールの一次回帰分析から換算係数を求めた。 For the measurement of ethanol, the sample is diluted 1 to 20 times so that the ethanol concentration in the sample is within the range of 0.2 to 1.0% (V / V), and the gas chromatograph for ethanol analysis (GL Sciences) (“Porapak® Type®” (trade name; manufactured by Waters) column was used, the carrier gas was nitrogen, and the flow rate was 60 mL / min). Separately, ethanol (manufactured by Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222) was separated under the same conditions, and conditions were set so that the measurement area and the weight of ethanol were standard curves with excellent linearity. Isopropanol was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of ethanol with respect to the internal standard.

 糖濃度の測定は、検体の糖濃度が10~300ppmの範囲内になるよう試料を10~100倍希釈し、糖分析用イオンカラムクロマトグラフ装置(DIONEX 社製)に供して分離定量した。使用したカラムはPA-1であり、溶出は水のみで1mL/minの速度で行った。溶出糖の定量のため、別途、5種の単糖(グルコース、マンノース、ガラクトース、キシロース、アラビノース)を同じ条件で分離し、測定面積と各糖の重量が直線性に優れた標準曲線の得られる条件を設定した。内部標準としてデオキシグルコースを用い、内部標準に対する各糖の一次回帰分析から換算係数を求めた。得られた各糖の換算係数と前記測定された面積から、試料に含まれる単糖の含量を算出した。 For the measurement of the sugar concentration, the sample was diluted 10 to 100 times so that the sugar concentration of the sample was in the range of 10 to 300 ppm, and subjected to separation and quantification using an ion column chromatograph for sugar analysis (manufactured by DIONEX Corporation). The column used was PA-1, and elution was performed with water alone at a rate of 1 mL / min. Separately, 5 types of monosaccharides (glucose, mannose, galactose, xylose, arabinose) are separated under the same conditions for quantification of eluted sugars, and a standard curve with excellent linearity in the measurement area and the weight of each sugar is obtained. A condition was set. Deoxyglucose was used as an internal standard, and a conversion coefficient was obtained from a linear regression analysis of each sugar relative to the internal standard. The content of monosaccharide contained in the sample was calculated from the conversion factor of each obtained sugar and the measured area.

 結果を、図5に示す。図5において、KO11-1、KO11-2はKO11株、ΔP-1、ΔP-2はKO11ΔP株の、それぞれ独立して行った2回の実験の結果を表す。KO11株とKO11ΔP株とを同一条件下で発酵試験に供したところ、KO11株は繰り返し発酵が出来なかったが、KO11ΔP株は3回の繰り返し発酵が可能であった(パネル(A):エタノール生産量;パネル(B):菌体重量)。KO11ΔP株において欠損しているPtsGは膜タンパク質であるため、KO11ΔP株では細胞膜の性質が変化して菌体の堅牢性が増したものと考えられる。 The results are shown in FIG. In FIG. 5, KO11-1 and KO11-2 represent the results of two experiments conducted independently for the KO11 strain and ΔP-1 and ΔP-2 for the KO11ΔP strain, respectively. When the KO11 strain and the KO11ΔP strain were subjected to a fermentation test under the same conditions, the KO11 strain could not be repeatedly fermented, but the KO11ΔP strain could be repeatedly fermented three times (panel (A): ethanol production). Amount; Panel (B): Cell weight). Since PtsG that is deficient in the KO11ΔP strain is a membrane protein, it is considered that in the KO11ΔP strain, the properties of the cell membrane changed and the robustness of the cells increased.

 残糖は、グルコースについては、1回目は同等であったが、2回目はKO11ΔP株の方が消費量が高く、残糖が少なくなっていた(パネル(C))。また、キシロースについては、1回目、2回目ともに、KO11ΔP株の方が消費量が高く、利用効率が高いことが確認された(パネル(D))。 Residual sugars were the same for glucose the first time, but the second time the KO11ΔP strain had higher consumption and less residual sugar (panel (C)). Regarding xylose, it was confirmed that the KO11ΔP strain had higher consumption and higher utilization efficiency in both the first and second rounds (panel (D)).

 5.ビタミン生産試験
 以下のものを使用した。
・YPD培地(Difco社製、Lot No. 7242780)
・グルコース(和光純薬工業株式会社製、特級、Lot No. ALP4694)
・キシロース(和光純薬工業株式会社製、特級、Lot No. PEH5709)
・99.5%エタノール(関東化学社製、特級、Lot No. 002XI222)
・50mL容のポリプロピレン製遠沈管(CORNING社製)
・回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L(24)型)
・回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L型)
・高速冷却遠心機(株式会社久保田製作所製、モデル6500型)
・遠心機(TOMY社製、モデルMX-305型)
5). The following vitamin production tests were used.
YPD medium (Difco, Lot No. 7242780)
・ Glucose (Wako Pure Chemical Industries, special grade, Lot No. ALP4694)
・ Xylose (Wako Pure Chemical Industries, special grade, Lot No. PEH5709)
・ 99.5% ethanol (Kanto Chemical Co., Ltd., special grade, Lot No. 002XI222)
・ 50mL polypropylene centrifuge tube (CORNING)
・ Rotary shake incubator (Takasugi Mfg. Co., Ltd., model TS-RS12L (24))
・ Rotary shake incubator (Takasugi Seisakusho, Model TS-RS12L)
・ High-speed cooling centrifuge (Model Kubota, Model 6500)
・ Centrifuge (TOMY model MX-305)

 培養には、YPD培地(Difco社製、Lot No. 7242780;3%(W/V)グルコースを含有)にキシロース(和光純薬工業株式会社製、特級、Lot No. PEH5709)3%(W/V)を添加して調製したグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地を使用した。 For culture, YPD medium (Difco, Lot No. 7724780; containing 3% (W / V) glucose) and xylose (Wako Pure Chemical Industries, special grade, Lot No. PEH5709) 3% (W / A YPD medium containing 3% glucose (W / V) and 3% xylose (W / V) prepared by adding V) was used.

 500mL容の三角フラスコに前述のグルコース3%(W/V)・キシロース3%(W/V)含有YPD培地100mLを分注し、湿菌体重量で30mgを無菌的に接種した。三角フラスコの蓋にはアルミキャップを使用した。培養には回転式振とう培養機(株式会社高杉製作所製、モデルTS-RS12L(24)型)を使用し、37℃、120rpmで15時間及び24時間の2つの時間条件で培養した。 A 500 mL Erlenmeyer flask was dispensed with 100 mL of the aforementioned YPD medium containing 3% glucose (W / V) and 3% xylose (W / V), and aseptically inoculated with 30 mg wet cell weight. An aluminum cap was used for the lid of the Erlenmeyer flask. The culture was carried out using a rotary shake incubator (model TS-RS12L (24), manufactured by Takasugi Seisakusho Co., Ltd.) at 37 ° C. and 120 rpm for 15 hours and 24 hours.

 各培養液50mLを遠心機(TOMY社製、モデルMX-305型)で5,000rpm、5分間遠心処理して上清を得た。得られた上清のビタミンB2含有量を、(財)日本食品分析センターに依頼し高速液体クロマトグラフ法にて蛍光検出器を用いビタミンB2を検出して定量した。
 具体的には、4mol/Lの酢酸ナトリウム溶液を用いてpH4.5に調整した培養液試料50mLに、2.5%タカジアスターゼ溶液を5mL加え、38℃で24時間酵素分解を行った後、水を加え100mLに定容し、0.45μmのメンブレンフィルターろ過後、10μLを高速液体クロマトグラフィに供した。蛍光検出器の励起波長は445nm、測定波長は530nmにて測定した。
50 mL of each culture solution was centrifuged at 5,000 rpm for 5 minutes with a centrifuge (Model MX-305, manufactured by TOMY) to obtain a supernatant. Vitamin B2 content in the obtained supernatant was quantified by requesting the Japan Food Analysis Center to detect vitamin B2 using a fluorescence detector by high performance liquid chromatography.
Specifically, 5 mL of a 2.5% Takadiastase solution was added to 50 mL of a culture solution sample adjusted to pH 4.5 using a 4 mol / L sodium acetate solution, followed by enzymatic degradation at 38 ° C. for 24 hours. Water was added to make a constant volume of 100 mL, and after filtration through a 0.45 μm membrane filter, 10 μL was subjected to high performance liquid chromatography. The excitation wavelength of the fluorescence detector was measured at 445 nm and the measurement wavelength was 530 nm.

 結果を図6に示す。縦軸は培養液100g中のビタミンB2量(mg)を表す。KO11ΔP株(「ΔP」)はYPD培地にて培養することでKO11株より大量にビタミンB2を生産した。 The results are shown in FIG. The vertical axis represents the amount of vitamin B2 (mg) in 100 g of the culture solution. The KO11ΔP strain (“ΔP”) produced vitamin B2 in a larger amount than the KO11 strain by culturing in the YPD medium.

 6.バイオマス由来の実液を用いた発酵試験
 実際の工場より得られる実液を用いてKO11株及びKO11ΔP株によるエタノールの生産量を評価した。
6). Fermentation test using real liquid derived from biomass Using actual liquid obtained from an actual factory, the amount of ethanol produced by KO11 strain and KO11ΔP strain was evaluated.

 バイオマスとして、針葉樹チップ及び広葉樹チップを用いた。これらのバイオマスを亜硫酸処理によりパルプ化する時に生じる黒液を、バイオマス糖液(糖化液)とした。バイオマス糖液に水酸化カルシウムを適宜添加してpH6.0になるように調整した後、80℃にて3時間加温処理して糖液中のフルフラールを分解した。バイオマス糖液は日を変えて各3回ずつ製造した。 Coniferous wood chips and hardwood wood chips were used as biomass. The black liquor produced when these biomasses were pulped by sulfite treatment was used as biomass sugar liquid (saccharified liquid). Calcium hydroxide was appropriately added to the biomass sugar solution to adjust to pH 6.0, and then heated at 80 ° C. for 3 hours to decompose furfural in the sugar solution. The biomass sugar solution was produced three times each on different days.

 このようにして得られたバイオマス糖液中の糖質を、前述の糖分析法にしたがって定量し、糖組成を評価した。それぞれの糖液中の濃度を表2に示す。 The sugar in the biomass sugar solution thus obtained was quantified according to the sugar analysis method described above, and the sugar composition was evaluated. Table 2 shows the concentration in each sugar solution.

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

 広葉樹由来の糖液は、木材中のへミセルロースであるキシランの分解によりキシロースが多い糖液になっている。一方、針葉樹由来の糖液は、へミセルロースがマンナンであるのでマンノースが多い糖液になっている。 The sugar solution derived from hardwood is a sugar solution rich in xylose due to the decomposition of xylan, which is hemicellulose in wood. On the other hand, the sugar solution derived from conifers is a sugar solution rich in mannose because hemicellulose is mannan.

 これらの糖液を用いて発酵試験を行った。KO11株及びKO11ΔP株ともに前述の方法にしたがって培養した。得られた菌体を遠心分離によって回収した。その後、絶乾重量で2%(W/V)となるように菌体をバイオマス糖液に添加し、30℃、120rpmにて5日間培養して、前述のようにしてエタノールの生産量を評価し、同時にバイオマス糖液中の残糖も定量して評価した。
 評価の結果を表3に示す。
Fermentation tests were conducted using these sugar solutions. Both KO11 strain and KO11ΔP strain were cultured according to the method described above. The obtained microbial cells were collected by centrifugation. Thereafter, the cells are added to the biomass sugar solution so that the dry weight becomes 2% (W / V), and cultured at 30 ° C. and 120 rpm for 5 days, and the amount of ethanol produced is evaluated as described above. At the same time, the residual sugar in the biomass sugar liquid was quantified and evaluated.
Table 3 shows the evaluation results.

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

 表3からわかるように、バイオマス糖液の利用による生成エタノール濃度は、KO11株について針葉樹が1.00%、広葉樹が0.03%であったのに対し、KO11ΔP株については針葉樹が0.99%、広葉樹が0.26%であった。したがって、KO11ΔP株は、元株のKO11株と比較して、針葉樹由来のバイオマス糖液を用いたエタノール生産性は同等であったうえ、広葉樹由来のバイオマス糖液を用いた場合には元株であるKO11株よりもエタノール生産性が高いことが判明した。 As can be seen from Table 3, the ethanol concentration produced by the use of biomass sugar solution was 1.00% for conifers and 0.03% for hardwoods for the KO11 strain, while 0.99% for conifers for the KO11ΔP strain. %, Broad-leaved tree was 0.26%. Therefore, compared to the original KO11 strain, the KO11ΔP strain had the same ethanol productivity using the coniferous-derived biomass sugar solution, and when the hardwood-derived biomass sugar solution was used, It was found that ethanol productivity was higher than that of a certain KO11 strain.

 この出願は、平成21年2月10日出願の日本特許出願、特願2009-029041に基づくものであり、特願2009-029041の明細書及び特許請求の範囲に記載された内容は、すべてこの出願明細書に包含される。
 
This application is based on Japanese Patent Application No. 2009-029041 filed on Feb. 10, 2009, and all the contents described in the specification and claims of Japanese Patent Application No. 2009-029041 Included in the application specification.

FERM P-21758(FERM BP-11221)
 
FERM P-21758 (FERM BP-11221)

Claims (10)

 ptsG遺伝子が破壊され又は欠損した、大腸菌KO11株の改変体である組換え大腸菌。 Recombinant E. coli, which is a variant of E. coli KO11 strain, in which the ptsG gene is disrupted or deleted.  好気的条件下でペントース資化性である、請求項1記載の組換え大腸菌。 The recombinant Escherichia coli according to claim 1, which is pentose assimilating under aerobic conditions.  大腸菌KO11株と比較してエタノール生産性及びビタミンB2生産性が高い、請求項1又は2記載の組換え大腸菌。 3. Recombinant E. coli according to claim 1 or 2, which has higher ethanol productivity and vitamin B2 productivity than E. coli KO11 strain.  受託番号FERM P-21758(FERM BP-11221)を有する、組換え大腸菌。 Recombinant E. coli having the deposit number FERM P-21758 (FERM BP-11221).  請求項1~4のいずれか1項記載の組換え大腸菌を使用してバイオマス糖化液を発酵させる工程を含む、エタノール及び/又はビタミンB2製造方法。 A method for producing ethanol and / or vitamin B2, comprising a step of fermenting a biomass saccharified solution using the recombinant Escherichia coli according to any one of claims 1 to 4.  発酵工程が、好気的条件下で行われる、請求項5記載の方法。 The method according to claim 5, wherein the fermentation step is performed under aerobic conditions.  バイオマス糖化液が、ヘキソースとペントースとが共存する糖化液である、請求項5又は6記載の方法。 The method according to claim 5 or 6, wherein the biomass saccharified solution is a saccharified solution in which hexose and pentose coexist.  発酵工程の前にバイオマスを糖化する工程を含む、請求項5~7のいずれか1項記載の方法。 The method according to any one of claims 5 to 7, comprising a step of saccharifying the biomass before the fermentation step.  発酵工程の後にもろみの固液分離工程、及びエタノールの蒸留工程及び/又は脱水工程を含む、請求項5~8のいずれか1項記載の方法。 The method according to any one of claims 5 to 8, further comprising a solid-liquid separation step of the mash and a distillation step and / or a dehydration step of ethanol after the fermentation step.  請求項5~9のいずれか1項記載の方法を用いて製造されたエタノール含有溶液。 An ethanol-containing solution produced using the method according to any one of claims 5 to 9.
PCT/JP2010/051779 2009-02-10 2010-02-08 Pentose-assimilating recombinant escherichia coli that produce ethanol and method for manufacturing ethanol using same Ceased WO2010092924A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009-029041 2009-02-10
JP2009029041 2009-02-10

Publications (1)

Publication Number Publication Date
WO2010092924A1 true WO2010092924A1 (en) 2010-08-19

Family

ID=42561766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/051779 Ceased WO2010092924A1 (en) 2009-02-10 2010-02-08 Pentose-assimilating recombinant escherichia coli that produce ethanol and method for manufacturing ethanol using same

Country Status (1)

Country Link
WO (1) WO2010092924A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013039085A (en) * 2011-08-18 2013-02-28 Ihi Corp Method for producing ethanol

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005503769A (en) * 2001-04-04 2005-02-10 ジェネンコー・インターナショナル・インク Isolated production and catabolic pathways of host cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005503769A (en) * 2001-04-04 2005-02-10 ジェネンコー・インターナショナル・インク Isolated production and catabolic pathways of host cells

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Abstracts of the Annual Meeting of the Society for Biotechnology, Japan (2008)", vol. 60, 2008, JAPAN, article KAZUYOSHI OTA: "Ethanol Seisansei Idenshi Kumikae Daichokin: Mokushitsukei Biomass Shigen kara no Nenryo Ethanol Seisan eno Riyo", pages: 7 *
EITEMAN, M.A. ET AL.: "A co-fermentation strategy to consume sugar mixtures effectively.", J BIOL ENG., vol. 2, no. 3, 2008 *
GONZALEZ, R. ET AL.: "Global gene expression differences associated with changes in glycolytic flux and growth rate in Escherichia coli during the fermentation of glucose and xylose.", BIOTECHNOL PROG., vol. 18, 2002, pages 6 - 20 *
NICHOLS, N.N. ET AL.: "Use of catabolite repression mutants for fermentation of sugar mixtures to ethanol.", APPL MICROBIOL BIOTECHNOL., vol. 56, 2001, pages 120 - 125 *
OHTA, K. ET AL.: "Genetic improvement of Escherichia coli for ethanol production: chromosomal integration of Zymomonas mobilis genes encoding pyruvate decarboxylase and alcohol dehydrogenase II.", APPL ENVIRON MICROBIOL., vol. 57, 1991, pages 893 - 900 *
PARK, Y.C. ET AL.: "Optimization of culture conditions for D-Ribose production by transketolase-deficient Bacillus subtilis JY1.", J. MIROBIOL. BIOTECHNOL., vol. 14, 2004, pages 665 - 672 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013039085A (en) * 2011-08-18 2013-02-28 Ihi Corp Method for producing ethanol

Similar Documents

Publication Publication Date Title
CN101821398B (en) Process for producing fermentation product from pretreated lignocellulosic feedstock
US20100268000A1 (en) Compositions and Methods for Fermentation of Biomass
Suryawati et al. Effect of hydrothermolysis process conditions on pretreated switchgrass composition and ethanol yield by SSF with Kluyveromyces marxianus IMB4
Danmaliki et al. Bioethanol production from banana peels
US9809867B2 (en) Carbon purification of concentrated sugar streams derived from pretreated biomass
Rahayu et al. Thermophilic ethanol fermentation from lignocellulose hydrolysate by genetically engineered Moorella thermoacetica
WO2010104896A1 (en) Production of fermentive end products from clostridium sp.
Xiros et al. Comparison of strategies to overcome the inhibitory effects in high-gravity fermentation of lignocellulosic hydrolysates
KR20200020961A (en) Processing of biomass materials
Biswas et al. Conversion of C6 and C5 sugars in undetoxified wet exploded bagasse hydrolysates using Scheffersomyces (Pichia) stipitis CBS6054
KR101144235B1 (en) Method for producing butanol using bioethanol waste fermented solution
Safari et al. Integrated ethanol and biogas production from pinewood
Kurian et al. Bioconversion of hemicellulose hydrolysate of sweet sorghum bagasse to ethanol by using Pichia stipitis NCIM 3497 and Debaryomyces hansenii sp
Sutton et al. Fermentation of sugarbeet pulp for ethanol production using bioengineered Klebsiella oxytoca strain P2
Anwar et al. Optimization of dilute acid pretreatment using response surface methodology for bioethanol production from cellulosic biomass of rice polish
WO2010092924A1 (en) Pentose-assimilating recombinant escherichia coli that produce ethanol and method for manufacturing ethanol using same
JP6167758B2 (en) Ethanol production method
Wang et al. Detoxification of lignocellulosic hydrolysates
Vincent Simultaneous co-saccharification and fermentation of sago hampas for bioethanol production
KR101447534B1 (en) Method for producing fermentable sugar solution containing less toxic acetate from lignocellulosic biomass
WO2014033256A1 (en) Process for the production of ethanol
US9359619B2 (en) Biomass liquefaction processes, and uses of same
WO2025049898A2 (en) Co-fermentation of mixed biomass feedstocks using thermophilic bacterial co-cultures
WO2015044101A1 (en) Process for conversion of pentose containing substrate
Luciana et al. Fermentation Strategies to Minimize Product Inhibition in Bioethanol Production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10741201

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10741201

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP